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iAbstract
The primary purpose of this thesis is to determine the global behaviour of some population and epidemiol-
ogy models through the application of Lyapunov functions. Using Lyapunov functions and applying these
to mathematical models of ODE systems representing different predator-prey models, we were able to
determine global assymptotic stability for their equilibrium points. Similarly, for the investigation into the
stability of epidemiological models, we were able to analyse various SIRS, SIR, SIS and SEIR models to
also conclude global assymptotic stability by implementing the Lyapunov direct method. We then continue
our investigation by the application of Lyapunov functions to PDE systems representing reaction-diffusion
systems of various predator-prey and epidemiological models. We have also been able to conclude global
assymptotic stability for their correspondng equilibriums in these cases. We then proceeded to create our
own reaction-diffusion system from a previously constructed ODE system and have been able to prove that
for both cases they have a globally assymptotically stable endemic equilibrium.
Acknowledgements
I would like to take this opportunity to thank everyone who has helped to make the completion of this
thesis possible. I would firstly like to offer my special thanks to my supervisor Dr. Nikos Kavallaris whose
patience and guidance helped me to achieve my best. I would also like to express my graditute to the
lecturers in the Mathematics department who have helped me through the last four years to reach this
point. I would next like to express my very great appreciation to my family: my mum and dad for their
love, constant support and motivating me when I needed it the most; my brother for always inspiring
me; and to my grandparents for the extra encouragement I never knew I needed. I would finally like to
acknowledge the help provided by the students on my course, particularly Gerard Coleman for keeping me
balanced throughout the stress of this past year.
Contents
1 Introduction 1
1.1 Mathematical Modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Stability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Lyapunov Stability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.4 LaSalle Invariance Principle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
2 Predator-Prey Models 4
2.1 A Predator-Prey Model Given by Hsu [5] . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.2 A Competing Predator-Prey Model Given by Chiu [3] . . . . . . . . . . . . . . . . . . . . . 6
3 Epidemiological Models 9
3.1 Modelling Epidemics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
3.2 SIRS Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
3.2.1 An SIRS Model Given by Korobeinikov and Wake [13] . . . . . . . . . . . . . . . . 10
3.3 SIR Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.3.1 An SIR Model Given by Korobeinikov and Maini [11] . . . . . . . . . . . . . . . . . 17
3.3.2 An SIR Model Given by Korobeinikov and Maini [12] . . . . . . . . . . . . . . . . . 20
3.3.3 An SIR Model Given by Korobeinikov [10] . . . . . . . . . . . . . . . . . . . . . . . 23
3.4 SIS Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.4.1 An SIS Model Given by Korobeinikov and Wake [13] . . . . . . . . . . . . . . . . . 28
3.5 SEIR Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.5.1 An SEIR Model Given by Korobeinikov and Maini [11] . . . . . . . . . . . . . . . . 36
3.5.2 An SEIR Model Given by Korobeinikov and Maini [12] . . . . . . . . . . . . . . . . 39
4 Reaction and Diffusion Models 44
4.0.3 A Diffusive Predator-Prey Model Given by Hsu [5] . . . . . . . . . . . . . . . . . . . 44
4.0.4 A Diffusive Holling-Tanner Predator-Prey Model Given by Peng and Wang [18] . . . 49
4.0.5 A New Diffusive SIRS System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
5 Conclusion and Further Work 53
ii
Chapter 1
Introduction
1.1 Mathematical Modelling
Mathematical modelling, as described by Andrews and McLone [1], is the representation of real world
problems in mathematical terms so that we may obtain a more precise understanding of its significant
properties. Mathematical models can be created for a vast amount of situations and, as explained by
Kalman [7], can be so accurate that they can actually take the place of building and testing physical
models. This has proven to be essential in some research where it may be time consuming, unethical or
expensive for practical experimentation.
Kapur [8] provides a twelve-point procedure for solving problems through mathematical modelling:
1. Be clear about the real world situation to be investigated. Find all its essential characteristics
relevant to the situation and find those aspects which are irrelevant or whose relevance is minimal.
It is important to decide what aspects must be considered and what aspects can be ignored.
2. Think about all the physical, chemical, biological, social, economic laws that may be relevant to the
situation. If necessary collect some data and analyse it to get some initial insight into this situation.
3. Formulate the problem in problem language.
4. Think about all the variables x1, x2, . . . , xn and parameters a1, a2, . . . , am involved. Classify these
into known and unknown ones.
5. Think of the most appropriate mathematical model and translate the problem suitably into mathe-
matical language in the form
fj
(
xi, ah,
∂
∂xi
,
∫
. . . dxi, d
)
≤ 0
i.e. in terms of algebraic, transcendental, differential, difference, integral, integro-differential,
differential-difference equations or inequalities.
6. Think of all possible ways of solving the equations of the model. The methods may be analytical,
numerical or simulation. Try to get as far as possible analytically, supplement this with numerical
and computer methods when necessary and use simulation when warranted.
7. If a reasonable change in the assumptions makes analytical solution possible, investigate the possibil-
ity. If new methods are required to solve the equations of the model, try to develop these methods.
8. Make an error analysis of the method used. If the error is not within acceptable limits, change the
method of solution.
9. Translate into problem language.
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10. Compare the predictions with available observations or data. If agreement is good, accept the model.
If the agreement is not good, examine the assumptions and approximations and change them in light
of the discrepancies observed and proceed as before.
11. Continue the process until a satisfactory model is obtained which explains all earlier data and obser-
vations.
12. Deduce conclusions from your model and test these conclusions against earlier data and additional
data that may be collected and see if the agreement still continues to be good.
This twelve-point procedure will aid in producing an accurate mathematical model for any real world
problem being investigated.
Throughout this thesis we will not be creating models but concentrating on models already produced
by other researchers.
1.2 Stability
This work will be investigating the stability of equilibrium points of the systems given.
Definition 1.2.1 (Equilibrium Points) Given a set of nonlinear first-order differential equations
x˙i = fi (x1, . . . , xn) for i = 1, . . . , n, (1.1)
where xi = xi(t), for time t ≥ 0, and x˙i = x˙i(t) stands for the time derivative of xi at time t whereas fi
are analytic functions. The equilibrium point, also known as an extreme point, is a solution that does not
change with time and thus has a derivative of zero. An equilibrium point of system (1.1) is therefore a
point x* = (x1*, . . . , xn*) for which fi (x1*, . . . , xn*) = 0.
Given a set of nonlinear first-order differential equations
x˙i = fi (x1, . . . , xn) for i = 1, . . . , n, (1.2)
where xi = xi(t) for time t and x˙i stands for the time derivative of xi for i = 1, . . . , n. Whereas fi are
analytic functions such that fi(0 . . . , 0) = 0 for i = 1, . . . , n so that the origin x = 0 is an equilibrium
point. Roughly speaking, an equilibrium point is classed as stable if all solutions starting at close points
stay close. A more mathematical definition is the following:
Definition 1.2.2 (Stability) The equilibrum point x = 0 of the system (1.2) is stable if for each ε > 0,
there exists δ > 0 such that ‖x(0)‖ < δ implies that ‖x(t)‖ < ε, for all t ≥ 0. The equilibrium point is
unstable if it is not stable. The equilibrium point is asymptotically stable if it is stable and there exists
c > 0 such that lim
t→+∞x(t) = 0 for all solutions with ‖x(0)‖ ≤ c.
1.3 Lyapunov Stability
In 1892, the Russian mathematician Aleksandr Mikhailovich Lyapunov developed a method to examine the
stability of equilibria of ordinary differential equations, known as the direct Lyapunov method. O’Regan,
Kelly, Korobeinikov, O’Callaghan and Pokrovskii [16] describe the direct method as one of the most power-
ful techniques for qualitative analysis of a dynamical system. This method is the most successful approach
to establish global properties of nonlinear systems, however, an auxiliary function with specific properties,
a Lyapunov function, is required and finding such a function can be a difficult and time consuming process.
Definition 1.3.1 (Lyapunov Test Function) For a function V (x), where x = (x1, x2, . . . , xn), if the
following conditions are satisfied:
1. V (x) and ∂V∂xi are continuous, for all x ∈ Rn and i = 1, . . . , n, not necessarily at the origin,
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2. V (0) = 0,
then we say that V (x) is a possible Lyapunov test function for system (1.2).
Theorem 1.3.1 (Lyapunov’s Direct Method) Using an appropriate Lyapunov test function it may be
possible to investigate the stability of an equilibrium point of the system of nonlinear differential equations
(1.2), as explained by Parks [17], by examining the rate of change with respect to time of V (x) calculated
as the Lyapunov derivative:
V˙ (x) =
n∑
i=1
∂V
∂xi
dxi
dt
=
n∑
i=1
∂V
∂xi
fi(x).
We can then interpret stability from V˙ as follows:
Definition 1.3.2 (Stable) If V (x) > 0 for x 6= 0 and V˙ (x) ≤ 0, then we say that V (x) is positive definite
and the origin (0, 0) of the system of ordinary differential equations (1.2) is stable.
Definition 1.3.3 (Asymptotically Stable) If V (x) > 0 for x 6= 0 and V˙ (x) < 0, then we say that
V (x) is positive definite and the origin (0, 0) of the system of ordinary differential equations (1.2) is
asymptotically stable.
Definition 1.3.4 (Unstable) If V˙ (x) > 0, then we say that V˙ (x) is positive definite and the origin (0, 0)
of the system of ordinary differential equations (1.2) is unstable.
1.4 LaSalle Invariance Principle
The LaSalle invariance principle provides a generalization of Lyapunov criteria for asymptotic stability.
This principle allows us to determine if an equilibrium point is asymptotically stable when we have a
negative semi-definite Lyapunov derivative.
Definition 1.4.1 (Invariant Set) A set M ⊂ Rn, n ≥ 1 is invariant with respect to system (1.2) if
x(0) ∈M ⇒ x(t) ∈M, for any t ∈ Rn.
Definition 1.4.2 (Trajectory) A trajectory of system (1.2) is the curve
{(φ1(t), φ2(t), . . . , φn(t)) : α < t < β}, where φ(t) = (φ1(t), φ2(t), . . . , φn(t)) is a solution of system (1.2).
Theorem 1.4.1 (LaSalle’s Invariance Principle) Assume that V (x) is a Lyapunov function of (1.2)
on a subset G ⊂ Rn, n ≥ 1. Define
S =
{
x ∈ G¯ : V˙ (x) = 0
}
, where G¯ is the closure of G. Let M be the maximal invariant subset of S. Then,
for t ≥ 0, every bounded trajectory of (1.2) that remains in G approaches the set M as t→ +∞.
Henceforth we will concentrate on the cases n = 2, 3.
As stated by O’Regan et al. [16], while the intention of Lyapunov was to study the stability of motion, the
direct Lyapunov method and the idea of an auxiliary function have found a large number of applications.
The main purpose of the current thesis is to concentrate on the construction of Lyapunov functionals for
different systems applied to various fields from population dynamics to epidemiology.
Chapter 2
Predator-Prey Models
When species interact the population dynamics of each species is affected, in general there is a whole
web of interacting species. For this thesis we consider populations in a predator-prey situation i.e., the
growth of one population is decreased whilst the other is increased. Throughout this investigation we will
concentrate on systems involving either two or three species.
2.1 A Predator-Prey Model Given by Hsu [5]
The first predator-prey work we will concentrate on is given by Hsu [5].
Let x(t), y(t) be the population densities of prey and predator at time t, respectively. Consider the following
Gause-type predator-prey system given by Hsu [5]:
x′ = xg(x)− cp(x)y,
y′ = (p(x)− d)y,
x(0) > 0, y(0) > 0,
(2.1)
where g(x) is the rate of change of population size of the prey species for which the population grows under
ideal conditions, p(x) is the specific growth rate of predator species, c > 0 is the conversion rate and d > 0
is the death rate of predator species. We assume g(x) and p(x) satisfy the following:
1. g(0) > 0 and there exists K > 0 such that g(K) = 0, g(x) > 0 for 0 ≤ x < K,
2. p(0) = 0, p′(x) > 0 for 0 ≤ x ≤ K,
where K is the maximum population size of the prey species that a given area can sustain indefinitely with
the resources available, known as the carrying capacity of the prey species.
From system (2.1), we can calculate the equilibrium as follows:
x′ = xg(x)− cp(x)y = 0
⇒ cp(x)y = xg(x)
y =
xg(x)
cp(x)
and
⇒ y′ = (p(x)− d)y = 0
y =
xg(x)
cp(x)
will therefore give:
(p(x)− d)xg(x)
cp(x)
= 0
4
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which is true if and only if p(x)− d = 0⇒ p(x) = d.
We can therefore see that x′ = 0 if and only if y = xg(x)cp(x) and y
′ = 0 if and only if x = x* where x*
satisfies p(x*)=d. We note that the curve y = xg(x)cp(x) the prey isocline and the curve x = x* predator
isocline.
To show that (x*,y*) is globally stable in the first quadrant of xy-plane we introduce, see [5], the fol-
lowing Lyapunov test function:
V (x, y) =
∫ x
x*
p(ε)− d
p(ε)
dε+ c
∫ y
y*
η − y*
η
dη. (2.2)
Then it follows that
V˙ (x, y) =
p(x)− d
p(x)
(xg(x)− cp(x)y) + cy − y*
y
(p(x)− d)y
=
p(x)− d
p(x)
(xg(x)− cp(x)y) + c(y − y*)(p(x)− d)
Which can be rearranged to give:
V˙ (x, y) =
p(x)− d
p(x)
(xg(x)− cp(x)y*− cp(x)(y − y*)) + c(y − y*)(p(x)− d)
= (p(x)− p(x*))
(
xg(x)
p(x)
− cy*− c(y − y*) + c(y − y*)
)
= c(p(x)− p(x*))
(
xg(x)
cp(x)
− y*
)
≤ 0,
(2.3)
if the horizontal line y = y* and the vertical line x = x* seperate the prey isocline y = xg(x)cp(x) into two
disjoint parts (see Fig.(2.1)).
y
x
(x*, y*)
y*
y =
xg(x)
p(x)
x* K
Figure 2.1:
We could also consider, see [5], the following mixed type Lyapunov function:
V (x, y) = yθ
∫ x
x*
p(ε)− d
p(ε)
dε+
∫ y
y*
ηθ−1(η − y*)dη. (2.4)
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Using system (2.1) it follows that
V˙ (x, y) =
[
yθ
(
p(x)− d
p(x)
)]
(xg(x)− p(x)y) +
[
θyθ−1
∫ x
x*
p(ε)− d
p(ε)
dε+ yθ−1(y − y*)
]
(p(x)− d)y
= yθ(p(x)− d)
[
xg(x)− p(x)y
p(x)
+ θ
∫ x
x*
p(ε)− d
p(ε)
dε+ (y − y*)
]
= yθ(p(x)− d)
[
xg(x)
p(x)
− y + θ
∫ x
x*
p(ε)− d
p(ε)
dε+ y − y*
]
.
= yθ(p(x)− d)
[
xg(x)
p(x)
− y* + θ
∫ x
x*
p(ε)− d
p(ε)
dε
]
.
Thus we have:
V˙ (x, y) = yθ(p(x)− d)
[
xg(x)
p(x)
− y* + θ
∫ x
x*
p(ε)− d
p(ε)
dε
]
.
We note that if we choose θ = 0 in the Lyapunov function (2.4) then V (x, y) becomes the Lyapunov
function (2.2).
2.2 A Competing Predator-Prey Model Given by Chiu [3]
The final predator-prey work we will concentrate on is given by Chiu [3]. This paper studies the global
asymptotic behaviour of the following three-dimensional predator-prey system which consists of two preda-
tor species x1, x2 competing for a single prey species S. Thus Chiu [3] provides the system:
dS
dt
= Sg(S)− p1(S)x1 − p2(S)x2,
dx1
dt
= q1(S)x1,
dx2
dt
= q2(S)x2,
S(0) > 0, x1(0) > 0, x2(0) > 0.
(2.5)
Chiu [3] provides the basic assumptions for system (4.12):
(H1) pi(·) ∈ C([0,∞),R), pi(0) = 0, and p′i(S) > 0 for all S > 0, i = 1, 2.
(H2) g(·) ∈ C([0,∞),R) and there exists K > 0 such that g(K) = 0 and (S −K)g(S) < 0 for all S > 0
with S 6= K.
(H3) qi(·) ∈ C([0,∞),R), q′i(S) > 0 for all S > 0 and there exists 0 < λi < K such that qi(λi) = 0 and
(S − λi)qi(S) > 0 for all S > 0 with S 6= λi, i = 1, 2.
In [3] it is proven that the solution (S(t), x1(t), x2(t)) of system (4.12) is bounded and positive for all t ≥ 0.
Moreover, S(t) ≤ K for t sufficiently large.
Under the assumptions (H1)-(H3) listed previously, there exists an equilibrium E* = (λ1, xˆ1, 0) of system
(4.12) with xˆ1 = h(λ1). Let us define, see [3],
F (S) =
xˆ1 − h(S)∫ S
λ1
(
q1(ε)
p1(ε)
)
dε
: (0, λ1) ∪ (λ1,K)→ R, (2.6)
then the following result holds, see also theorem 3.4.1 in [3].
2.2. A COMPETING PREDATOR-PREY MODEL GIVEN BY CHIU [?C] 7
Theorem 2.2.1 Let the conditions (H1)-(H3) hold and let (S(t), x1(t), x2(t)) be the solution of system
(4.12). If q2(λ1) ≤ 0 and there exists:
1. θ ∈ R such that
θ ≥ F (S), for all S ∈ (0, λ1), and θ ≤ F (S), for all S ∈ (λ1,K), (2.7)
2. c > 0 such that for all S > 0 with S 6= λ1,
∆(S) = − q1(S)
p1(S)
p2(S) + c [θq1(S) + (q2(S)− q2(λ1))] < 0. (2.8)
Then (S(t), x1(t), x2(t))→ (λ1, xˆ1, 0) as t→∞.
Proof. We consider the potential Lyapunov function, see also [3],
V (S, x1, x2) =
∫ x1
xˆ1
εθ−1(ε− xˆ1)dε+ xθ1
∫ S
λ1
q1(ε)
p1(ε)
dε+ cxθ1x2.
It can be seen that V (S, x1, x2) ∈ C1(R3+,R), V (λ1, xˆ1, 0) = 0, and V (S, x1, x2) > 0 for (S, x1, x2) ∈
R3+ − {(λ1, xˆ1, 0)}. Then the derivative of V (S, x1, x2) along the trajectory (see definition 1.4.2) of system
(4.12) is
V˙ (S, x1, x2) =
(
xθ1
q1(S)
p1(S)
)
(Sg(S)− p1(S)x1 − p2(S)x2)
+
(
xθ−11 (x1 − xˆ1) + θxθ−11
∫ S
λ1
q1(ε)
p1(ε)
dε+ θcxθ−11 x2
)
q1(S)x1
+ c1x
θ
1q2(S)x2
Which can be rearranged to give:
V˙ (S, x1, x2) = x
θ
1
(
q1(S)
p1(S)
)
(Sg(S)− p1(S)x1 − p2(S)x2)
+
(
xθ1 − xˆ1xθ−11
∫ S
λ1
q1(ε)
p1(ε)
dε+ cθxθ−11 x2
)
q1(S)x1
+ cxθ1q2(S)x2
After further calculations we obtain:
V˙ (S, x1, x2) = x
θ
1
(
q1(S)
p1(S)
)
(Sg(S)− p1(S)x1)
+
(
xθ1 − xˆ1xθ−11
∫ S
λ1
q1(ε)
p1(ε)
dε
)
q1(S)x1
− xθ1
q1(S)
p1(S)
p2(S)x2 + cθx
θ
1q1(S)x2 + cx
θ
1q2(S)x2
= xθ1
q1(S)
p1(S)
Sg(S)− xθ1
q1(S)
p1(S)
p1(S)x1 + x
θ
1q1(S)x1
− xˆ1xθ−11 q1(S)x1 + θxθ−11
∫ S
λ1
q1(ε)
p1(ε)
dεq1(S)x1 − xθ1
q1(S)
p1(S)
p2(S)x2
+ cθxθ1q1(S)x2 + cx
θ
1q2(S)x2
= xθ1
q1(S)
p1(S)
Sg(S)− xθ+11 q1(S) + xθ+11 q1(S)− xθ1xˆ1q1(S) + θxθ1q1(S)
∫ S
λ1
q1(ε)
p1(ε)
dε
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− xθ1
q1(S)
p1(S)
p2(S)x2 + cθx
θ
1x2 + cx
θ
1q2(S)x2
= xθ1q1(S)
(
Sg(S)
p1(S)
− xˆ1 + θ
∫ S
λ1
q1(ε)
p1(ε)
dε
)
+ xθ1x2
(
− q1(S)
p1(S)
p2(S) + c (θq1(S) + q2(S))
)
= xθ1q1(S)
(
Sg(S)
p1(S)
− xˆ1 + θ
∫ S
λ1
q1(ε)
p1(ε)
dε
)
+ xθ1x2
[
− q1(S)
p1(S)
p2(S) + c (θq1(S) + q2(S))
]
+ cxθ1q2(λ1)x2 − cxθ1q2(λ1)x2
= xθ1q1(S)
(
Sg(S)
p1(S)
− xˆ1 + θ
∫ S
λ1
q1(ε)
p1(ε)
dε
)
+ cxθ1q2(λ1)x2
+ xθ1x2
[
− q1(S)
p1(S)
p2(S) + c
[
θq1(S) + (q2(S)− q2(λ1))
]]
.
From the assumption q2(λ1) ≤ 0 and using (4.15), (4.16), it follows that
V˙ (S, x1, x2) ≤ 0, for 0 < S < K, x1 > 0, x2 > 0.
Hence we complete the proof of theorem (3.3.3) by LaSalle’s invariance principle (see definition ??).
Chapter 3
Epidemiological Models
3.1 Modelling Epidemics
Definition 3.1.1 (Classical Assumptions) The host population is subdivided into distinct classes ac-
cording to the health of its members. The basic variables identifying the state of the population are the
three epidemiological classes:
 S(t) the number of susceptibles at time t; the individuals who are healthy and can be infected,
 I(t) the number of infectives at time t; the individuals who are infected and are able to transmit the
disease,
 R(t) the number of immune at time t; the individuals who are immune because they have been infected
and have now either recovered or died.
These classical assumptions will be used throughout all of the models investigated throughout this thesis.
After the basic state variables introduced above, further simplification may be introduced concerning the
disease progression and effect. A basic distinction may be done between the diseases that impart lifelong
immunity, temporary immunity and no immunity which lead to the SIR models, SIRS models and SIS
models respectively.
Kermack and McKendrick [9] summarise the problem as follows: one (or more) infected person is in-
troduced into a community of individuals susceptible to the disease in question. The disease spreads from
the affected to the unaffected by contact infection. Each infected person runs through the course of his
sickness and is removed from the number of those who are sick, by recovery or by death.
The method of Lyapunov functions has been used extensively in mathematical biology and one of the
main areas it is applied to is epidemiology. We can use Lyapunov functions to investigate the stability of
infection-free and endemic equilibriums of the different systems. Throughout this thesis we will concentrate
on a small number of papers which look at a variety of different epidemiological systems.
3.2 SIRS Models
The first type of epidemiological model we will concentrate on is the SIRS model. Here we divide the
population, of size N , into the subpopulations defined in (3.1). We assume that an individual begins in
the susceptibles compartment, after infection moves to the infective compartment and then continues into
the removed compartment as a result of recovery. For our SIRS models we assume that recovery implies
temporary immunity and thus the individuals in the removed compartment would return to the susceptible
compartment after the recovery period. We will also assume that the population size N is constant which
implies that deaths are balanced by births.
9
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3.2.1 An SIRS Model Given by Korobeinikov and Wake [13]
The SIRS model we will investigate is given by Korobeinikov and Wake [13] and is described via the
transfer diagram in Figure 3.1. In this model the births are proportional to the population size N with
a birth rate γ, all disease-associated deaths are from the R compartment and the susceptibles and the
infectives whom die from causes not connected with the disease are modelled with σ ≥ 0. Furthermore,
we assume that the vaccination of the susceptibles is proportional to the susceptibles population which
therefore gives the rate σ as the sum of the death rate of susceptibles and of the vaccination rate. In this
case, σ does not necessarily equal γ.
γ(NpI)
S
σS
β SI
N
I
γpI
σI
δI
R
γ − σ(S + I)
αR
S
Figure 3.1: Transfer diagram of the SIRS model given by Korobeinikov and Wake [13].
Korobeinikov and Wake [13] explain that there are two different types of transmission to be modelled; hor-
izontal transmission and vertical transmission. An infection can be transmitted through contacts between
the infectives and the susceptibles which is an example given of horizontal transmission for which, in this
model, we assume to occur according to the mass action incidence βSIN . An example for vertical transmis-
sion can be, for some diseases, the transmission of the disease passed on from an infective parent to their
offspring. This has been incorporated into this model by assuming that a fraction p of the offspring from
the infectives are infected at birth, and hence, a part of birth flux, pγI, enters the infective compartment
while the remaining births, γN − pγI, come to the susceptibles compartment (see Figure 3.1).
For this model Korobeinikov and Wake [13] have given an average life expectancy of the susceptibles 1σ , an
average infective period 1δ and an average period of immunity
1
α which results in the following differential
system
S˙ = (γ + α)N − βSI
N
− (α+ pγ)I − (α+ σ)S,
I˙ = β
SI
N
− (δ + σ − pγ)I.
(3.1)
For this system we do not need an equation for the removed class R as we have N = S + I +R which is a
constant.
We will now study the stability of the equilibrium points of system (3.5). This system has two equilibria:
an infection-free equilibrium and an endemic equilibrium.
Finding the infection-free equilibrium:
Infection-free ⇒ I0 = 0.
We need to find S0 such that S˙ = 0:
S˙ = (γ + α)N − βS0I0
N
− (α+ pγ)I0 − (α+ σ)S0 = 0
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⇒ (γ + α)N − βS0(0)
N
− (α+ pγ)(0)− (α+ σ)S0 = 0
⇒ (γ + α)N − (α+ σ)S0 = 0
⇒ (α+ σ)S0 = (γ + α)N
⇒ S0 =
(
γ + α
α+ σ
)
N.
Thus we have an infection-free equilibrium E0 = (S0, I0), with
S0 =
(
γ + α
α+ σ
)
N, I0 = 0.
Finding the endemic equilibrium:
First we need to find S* such that I˙ = 0:
I˙ = β
S*I*
N
− (δ + σ − pγ)I* = 0
⇒ βS*I*
N
= (δ + σ − pγ)I*
⇒ S* = (δ + σ − pγ)N
β
.
Given R0 =
β(α+ γ)
(α+ σ)(δ + σ − pγ) , we can rearrange S* as follows:
S* =
(
δ + σ − pγ
β
)
R0
N
R0
=
(
δ + σ − pγ
β
)(
β(α+ γ)
(α+ σ)(δ + σ − pγ)
)
N
R0
=
(
α+ γ
α+ σ
)
N
R0
.
Next we need to find I* such that S˙ = 0:
S˙ = (γ + α)N − βS*I*
N
− (α+ pγ)I*− (α+ σ)S* = 0
⇒ βS*I*
N
+ (α+ pγ)I* = (γ + α)N − (α+ σ)S*
⇒ I*
(
β
S*
N
+ α+ pγ
)
= (γ + α)N − (α+ σ)S*
⇒ I* = (γ + α)N − (α+ σ)S*
β S*N + α+ pγ
Substituting in S*=
(
α+ γ
α+ σ
)
N
R0
=
(δ + σ − pγ)N
β
, we derive:
I* =
(γ + α)N − (α+ σ)
(
(δ+σ−pγ)N
β
)
β
N
(
(δ+σ−pγ)N
β
)
+ α+ pγ
=
(
β(γ + α)− (α+ σ)(δ + σ − pγ)
β(δ + σ − pγ + α+ pγ)
)
N
=
(
β(γ + α)− (α+ σ)(δ + σ − pγ)
β(α+ δ + σ)
)
N.
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Rearranging gives:
I* =
α+ γ
α+ δ + σ
(
β(α+ γ)− (α+ σ)(δ + σ − pγ)
β(α+ γ)
)
N
=
α+ γ
α+ δ + σ
(
1− (α+ σ)(δ + σ − pγ)
β(α+ γ)
)
N.
Given R0 =
β(α+ γ)
(α+ σ)(δ + σ − pγ) , we can rearrange I* as follows:
I* =
α+ γ
α+ δ + σ
(
1− 1
R0
)
N.
Thus we have an endemic equilibrium E* = (S*, I*), with
S* =
(
α+ γ
α+ σ
)
N
R0
, I* =
α+ γ
α+ δ + σ
(
1− 1
R0
)
N.
For this model, the basic reproduction number, that is an average number of secondary cases produced by
a single infective introduced into an entirely susceptible population, is given as the parameter
R0 =
β(α+ γ)
(α+ σ)(δ + σ − pγ) .
Korobeinikov and Wake [13] give the condition R0 > 1 as this will ensure the existence of the positive
endemic equilibrium state E* and thus we will henceforth assume that this condition holds.
For α, p 6= 0 the positive quadrant R2+ of the SI plane is not an invariant set of system (3.1) as at S = 0
we have S˙ < 0 for all I >
(
α+ γ
α+ pγ
)
N . Consequently the boundary S = 0 is penetrable from R2+.
To avoided this, Korobeinikov and Wake [13] suggest the use of the substitution (S, I) → (P, I) where
P = S +
(
α+ pγ
β
)
N .
We will now create a new system of differential equations using these substitutions.
First calculating P˙ :
P˙ = S˙ = (γ + α)N − βSI
N
− (α+ pγ)I − (α+ σ)S.
Note that we have
P = S +
(
α+ pγ
β
)
N ⇒ S = P −
(
α+ pγ
β
)
N
and thus substituting in S we derive:
P˙ = (γ + α)N − β I
N
[
P −
(
α+ pγ
β
)
N
]
− (α+ pγ)I − (α+ σ)
[
P −
(
α+ pγ
β
)
N
]
= (γ + α)N − βPI
N
+ (α+ pγ)I − (α+ pγ)I − (α+ σ)P +
(
(α+ σ)(α+ pγ)
β
)
N
= (γ + α)N +
(
(α+ σ)(α+ pγ)
β
)
N − βPI
N
− (α+ σ)P
=
[
γ + α+
(α+ σ)(α+ pγ)
β
]
N − βPI
N
− (α+ σ)P
= γˆN − βPI
N
− σˆP
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where γˆ = γ + α+
(α+ σ)(α+ pγ)
β
and σˆ = α+ σ.
Now calculating I˙ we have:
I˙ = β
SI
N
− (δ + σ − pγ)I
and substituting in S = P −
(
α+ pγ
β
)
N we derive:
I˙ = β
I
N
[
P −
(
α+ pγ
β
)
N
]
− (δ + σ − pγ)I
= β
PI
N
− (α+ pγ)I − (δ + σ − pγ)I
= β
PI
N
− (α+ pγ + δ + σ − pγ)I
= β
PI
N
− (α+ δ + σ)I
= β
PI
N
− δˆI
where δˆ = α+ δ + σ.
Thus in the new variables, we have the following differential system
P˙ = γˆN − βPI
N
− σˆP,
I˙ = β
PI
N
− δˆI,
(3.2)
where γˆ = γ + α+
(α+ σ)(α+ pγ)
β
, δˆ = α+ δ + σ and σˆ = α+ σ.
System (3.2) obtained by the shift of system (3.1) along the S axis inherits the global properties of system
(3.1) and vice versa. When α, p = 0 i.e., for considering the SIR model, system (3.2) coincides with system
(3.1). In the new variables, we can derive the endemic equilibrium as follows:
First we need to find P* such that I˙ = 0:
I˙ = β
P*I*
N
− δˆI* = 0
⇒ βP*I*
N
= δˆI*
⇒ P* = δˆN
β
Given R0 =
βγˆ
σˆδˆ
, we can rearrange P* as follows:
P* =
δˆ
β
R0
N
R0
=
δˆβγˆ
βσˆδˆ
N
R0
=
γˆ
σˆ
N
R0
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Next we need to find I* such that P˙ = 0:
P˙ = γˆN − βP*I*
N
− σˆP* = 0
⇒ βP*I*
N
= γˆN − σˆP*
⇒ I* =
(
γˆN − σˆP*
βP*
)
N
=
(
γˆN
βP*
− σˆ
β
)
N
Substituting in P*=
γˆ
σˆ
N
R0
=
δˆN
β
we derive:
I* =
(
γˆN
β
[
β
δˆN
]
− σˆ
β
)
N
=
(
γˆ
δˆ
− σˆ
β
)
N
=
γˆ
δˆ
(
1− σˆδˆ
βγˆ
)
N
=
γˆ
δˆ
(
1− 1
R0
)
N.
By noting that R0 =
βγˆ
σˆδˆ
, in the new variables the endemic equilibrium state E*= (P*, I*) has coordinates
P* =
γˆ
σˆ
N
R0
, I* =
γˆ
δˆ
(
1− 1
R0
)
N (3.3)
and is therefore the only equilibrium point for P, I > 0.
It follows from (3.2) that
β
P*I*
N
=
β
N
(
δˆN
β
)
I* = δˆI*
and
δˆI* = γˆ
(
1− 1
R0
)
N = γˆ
(
1− σˆδˆ
βγˆ
)
N
= γ
(
βγˆ − σˆδˆ
βγˆ
)
N =
(
βγˆ − σˆδˆ
β
)
N
= γˆN − σˆ δˆN
β
= γˆN − σˆP*.
Thus we have
β
P*I*
N
= γˆN − σˆP* = δˆI*. (3.4)
Global properties of system (3.2), and therefore system (3.1), are given by Korobeinikov and Wake [13] in
the following theorem:
Theorem 3.2.1 The endemic equilibrium state E* of system (3.2) (and hence, that of system (3.1)) is
globally stable.
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Proof. We consider the Lyapunov test function
V (P, I) = P*
(
P
P*
− ln P
P*
)
+ I*
(
I
I*
− ln I
I*
)
(3.5)
which is defined and continuous for all P, I > 0 and satisfies
∂V
∂P
= 1− P*
P
and
∂V
∂I
= 1− I*
I
.
Note that here we can determine the type of equilibrium point.
Definition 3.2.1 (Extrema: Maximum or Minimum) Extreme points are points of a function whose
derivative is zero and can be classified into maximum or minimum points, either locally or globally. Given
x = (x1, . . . , xn) and a function f(x), defined on the domain Ω ⊂ Rn, with an extreme point
x* = (x1*, . . . , xn*) we can define:
1. f(x) has a local minimum at x* if f(x) ≥ f(x*) for every x in an open interval containing x*.
2. f(x) has a global minimum at x* if f(x) ≥ f(x*) for every x in Ω.
3. f(x) has a local maximum at x* if f(x) ≤ f(x*) for every x in an open interval containing x*.
4. f(x) has a global maximum at x* if f(x) ≤ f(x*) for every x in Ω.
For the Lyapunov function (3.5) we can see that ∂V∂P =
∂V
∂I = 0 at E* as defined in (3.3). To determine if
the Lyapunov function has a maximum or minimum extreme point at E*, we use the Hessian matrix to
complete the second derivative test explained in the following definitions.
Definition 3.2.2 (Hessian Matrix) A Hessian matrix is a square matrix containing second-order partial
derivatives of a given function f(xi) and we denote as:
∂2f
∂x21
∂2f
∂x1∂x2
· · · ∂
2f
∂x1∂xn
∂2f
∂x2∂x1
∂2f
∂x22
· · · ∂
2f
∂x2∂xn
...
...
. . .
...
∂2f
∂xn∂x1
∂2f
∂xn∂x2
· · · ∂
2f
∂x2n

. (3.6)
The Hessian matrix describes the local curvature of a function of many variables and can be used to
determine if an equilibrium point is a maximum or minimum extremum using the second derivative test.
Definition 3.2.3 (The Second Derivative Test) Given x = (x1, . . . , xn) and a function f(x), defined
on the domain Ω ⊂ Rn, with an extreme point x* = (x1*, . . . , xn*). Using the Hessian matrix defined in
section 3.2.2, we can determine the type of extreme point.
Firstly we denote Di is the determinant of the Hessian matrix with i rows and columns, where 1 ≤ i ≤ n
i.e.,
D1 =
∂2f
∂x21
, D2 =
∣∣∣∣∣∣∣∣∣
∂2f
∂x21
∂2f
∂x1∂x2
∂2f
∂x2∂x1
∂2f
∂x22
∣∣∣∣∣∣∣∣∣ , . . . , Dn =
∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣
∂2f
∂x21
∂2f
∂x1∂x2
· · · ∂
2f
∂x1∂xn
∂2f
∂x2∂x1
∂2f
∂x22
· · · ∂
2f
∂x2∂xn
...
...
. . .
...
∂2f
∂xn∂x1
∂2f
∂xn∂x2
· · · ∂
2f
∂x2n
∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣
.
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1. If all Di > 0, for 1 ≤ i ≤ n, at the extreme point x*, then f(x) has a minimum extreme point at
x* and the function f(x) is concave upward at the extreme point x*.
2. If all (−1)iDi > 0, for 1 ≤ i ≤ n, at the extreme point x*, then f(x) has a maximum extreme point
at x* and the function f(x) is concave downward (or convex) at the extreme point x*.
For the Lyapunov function (3.5) we can derive the second derivatives as follows:
∂2V
∂P 2
=
P*
P 2
> 0,
∂2V
∂I2
=
I*
I2
> 0 and
∂2V
∂P∂I
=
∂2V
∂I∂P
= 0.
Thus, by the second derivative test we have
D1 =
∂2V
∂P 2
> 0 and D2 =
∣∣∣∣∣∣∣∣
∂2V
∂P 2
∂2V
∂P∂I
∂2V
∂I∂P
∂2V
∂I2
∣∣∣∣∣∣∣∣ > 0. (3.7)
We can therefore conclude that the endemic equilibrium state E*= (P*, I*) is the only local station-
ary point of the function and is a minimum extreme point. As V (P, I) → ∞ at the boundary, we have
V (P, I) ≥ V (P*, I*) and thus the function is bounded from below. Consequently E*, as defined in (3.3),
is the only extremum and the global minimum of the function in R2+ and hence the function (3.5) is indeed
a Lyapunov function.
In the case of system (3.2), using (3.4), the function V (P, I) satisfies
V˙ (P, I) =
(
1− P*
P
)(
γˆN − βPI
N
− σˆP
)
+
(
1− I*
I
)(
β
PI
N
− δˆI
)
.
= γˆN − βPI
N
− σˆP − γˆN P*
P
+ β
P*
N
I + σˆP* + β
PI
N
− δˆI − βPI*
N
+ δˆI*
= γˆN − γˆN P*
P
+ σˆP* + δˆI*− σˆP − δˆI + βP*
N
I − βPI*
N
Note that γˆN − σˆP* = δˆI*⇒ σˆP* + δˆI* = γˆN , therefore:
V˙ (P, I) = γˆN − γˆN P*
P
+ γˆN − σˆP − δˆI + βP*
N
I + β
PI
N
− βPI
N
− βPI*
N
Also note that γˆN − σˆP* = δˆI*⇒ σˆP* = γˆN − δˆI*⇒ σˆP = σˆP* PP* = PP*(γˆN − δˆI*), thus:
V˙ (P, I) = γˆN − γˆN P*
P
+ γˆN −
[
P
P*
(γˆN − δˆI*)
]
− δˆI + βP*
N
I − βPI*
N
= γˆN − γˆN P*
P
+ γˆN − γˆN P
P*
+ δˆI*
P
P*
− δˆI + βP*I*
N
I
I*
− βP*I*
N
P
P*
= γˆN
(
1− P*
P
− P
P*
+ 1
)
+ δˆI*
P
P*
− δˆI* I
I*
+ δˆI
I
I*
− δˆI* P
P*
= −γˆN
(
P*
P
+
P
P*
− 2
)
= −γˆN P*
P
(
1− 2 P
P*
+
(
P
P*
)2)
= −γˆN P*
P
(
1− P
P*
)2
.
Thus we have
V˙ (P, I) = −γˆN P*
P
(
1− P
P*
)2
≤ 0, for all P, I ≥ 0. (3.8)
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The equality V˙ (P, I) = 0 holds only on the straight line P = P* (see [13]). Since the endemic equilibrium
state E* is the only invariant set of system (3.2) on the straight line P = P*, by the asymptotic stability
theorem 1.3.3, the equilibrium E*, as defined in (3.3), is globally asymptotically stable. The theorem is
proven.
Note that if we were to consider permanent immunity for the model (3.1) this implies that average period
of immunity 1α is infinite and thus α = 0 which would therefore reduce the SIRS model to the SIR model.
Further examples of SIR models follow.
3.3 SIR Models
The second type of epidemiological model we will concentrate on is the SIR model. Following classical as-
sumptions we divide the population, of size N , into the subpopulations as defined in (3.1). We assume that
an individual begins in the susceptibles compartment, after infection moves to the infective compartment
and then continues into the removed compartment as a result of recovery, isolation or death by disease. For
our SIR models we assume that recovery implies permanent immunity. For simplicity, we will normalize
the population size N to 1 for each of these models; i.e. now S, I and R are, respectively, the fractions of
the susceptibles, the infectives and the removed in the population, and thus S + I +R = 1 holds.
3.3.1 An SIR Model Given by Korobeinikov and Maini [11]
The first SIR model we will concentrate on is a model with nonlinear incidence. Korobeinikov and Maini
[11] note that there are a variety of reasons why the standard bilinear incidence rate may require modifi-
cation. The incidence rate of the form βIpSq, where S and I are respectively the number of susceptible
and infective individuals in the population (or the fractions of the susceptible and infective), and β, p and
q are positive constants, is the most common nonlinear incidence rate and thus is what we will investigate.
Applying the direct Lyapunov method, we can consider the global properties of SIR models with the
incidence rate of the form βIpSq for the particular case p ≤ 1. Korobeinikov and Maini [11] construct
a Lyapunov function for models with bilinear incidence and we will use their approach to show that the
condition p < 1 is a sufficient condition for global stability.
For the incidence rate of the form βIpSq, the basic SIR model is given by Korobeinikov and Maini [11] as:
S˙ = b− βIpSq − µS,
I˙ = βIpSq − δI, (3.9)
Here b is the birth rate, µ is the susceptible death rate and δ is the infective removal rate (including mortal-
ity rate). We omit the equations for the recovered population R; the constant population size assumption
enables us to do so.
If 0 < p < 1 holds, then system (3.9) has two equilibrium states: an infection-free equilibrium and an
endemic equilibrium.
Finding the infection-free equilibrium:
Infection-free ⇒ I0 = 0.
First we need to find S0 such that S˙ = 0:
S˙ = b− βIp0Sq0 − µS0 = 0
⇒ b− β(0)pSq0 − µS0 = 0
⇒ b− µS0 = 0
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⇒ µS0 = b
⇒ S0 = b
µ
.
Thus we have an infection-free equilibrium Q0, see also [11], with the coordinates S0 =
b
µ
, I0 = 0.
Finding the endemic equilibrium:
First we will consider I˙ = 0:
I˙ = β(I*)p(S*)q − δI* = 0
⇒ δI* = β(I*)p(S*)q. (3.10)
Now we will consider S˙ = 0:
S˙ = b− β(I*)p(S*)q − µS* = 0
⇒ µS* + β(I*)p(S*)q = b. (3.11)
Substituting (3.10) into (3.11):
µS* + δI* = b. (3.12)
Thus, using (3.10) and (3.12), we have the endemic equilibrium state Q*= (S*, I*), such that
δI* = β(I*)p(S*)q, µS* + δI* = b. (3.13)
We will now consider the following theorem, as given by Korobeinikov and Maini [11], and apply it instead
to the SIR system (3.9) to confirm their conclusion.
Theorem 3.3.1 If p ≤ 1, then the endemic equilibrium state Q* of the model (3.9) is globally asymptoti-
cally stable. The stability does not depend on the value of the parameter q.
Proof. Assume that p, q 6= 1. Then for the SIR model, we consider a test Lyapunov function of the form
V (S, I) = S
(
1 +
1
q − 1
(
S*
S
)q)
+ I
(
1 +
1
p− 1
(
I*
I
)p)
. (3.14)
This function is defined and continuous for all S, I > 0 and satisfies
∂V
∂S
= 1−
(
S*
S
)q
and
∂V
∂I
= 1−
(
I*
I
)p
.
Note that for this function we have ∂V∂S =
∂V
∂I = 0 at Q*, as defined in (3.13), and thus we can determine the
type of equilibrium point. For the possible Lyapunov function (3.14) we can derive the second derivatives
as follows:
∂2V
∂S2
=
q
S
(
S*
S
)q
> 0,
∂2V
∂I2
=
p
I
(
I*
I
)p
> 0 and
∂2V
∂S∂I
= 0.
Thus, by the second derivative test, see definition 3.2.3, we can conclude that the endemic equilibrium
state Q*= (S*, I*) is the only extremum and the global minimum of the function in the positive octant
R3+ and hence V (S, I) ≥ V (S*, I*). Consequently, the function (3.14) is indeed a Lyapunov function.
Using the equalities
b = µS* + δI*, β(I*)p(S*)q = δI* (3.15)
for the equilibrium state Q*, as defined in (3.13), the Lyapunov function (3.14) satisfies:
V˙ (S, I) =
(
1−
(
S*
S
)q)
(b− βIpSq − µS) +
(
1−
(
I*
I
)p)
(βIpSq − δI)
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= b− βIpSq − µS − b
(
S*
S
)q
+ βIp(S*)q + µS
(
S*
S
)q
+ βIpSq − δI − β(I*)pSq + δI
(
I*
I
)p
= b− µS − b
(
S*
S
)q
+ βIp(S*)q + µS
(
S*
S
)q
− δI − β(I*)pSq + δI
(
I*
I
)p
Using now (3.15) we obtain:
V˙ (S, I) = [µS* + δI*]− µS − [µS* + δI*]
(
S*
S
)q
+ δI*
(
I
I*
)p
+ µS
(
S*
S
)q
− δI − δI*
(
S
S*
)q
+ δI
(
I*
I
)p
= µS* + δI*− µS − µS*
(
S*
S
)q
− δI*
(
S*
S
)q
+ δI*
(
I
I*
)p
+ µS
(
S*
S
)q
− δI − δI*
(
S
S*
)q
+ δI
(
I*
I
)p
= µS*
[
1− S
S*
−
(
S*
S
)q
+
S
S*
(
S*
S
)q]
+ δI*
[
1−
(
S*
S
)q
+
(
I
I*
)p
− I
I*
−
(
S
S*
)q
+
I
I*
(
I*
I
)p]
= µS*
[
1− S
S*
−
(
S*
S
)q
+
S
S*
(
S*
S
)q]
+ δI*
[
2−
(
S*
S
)q
−
(
S
S*
)q]
+ δI*
[
+
(
I
I*
)p
− I
I*
+
I
I*
(
I*
I
)p
− 1
]
= µS*
(
1− S
S*
)(
1−
(
S*
S
)q)
− δI*
(
S
S*
)q [((S*
S
)q)2
− 2
(
S*
S
)q
+ 1
]
+ δI*
(
1−
(
I*
I
)p)(( I
I*
)p
− I
I*
)
= µS*
(
1− S
S*
)(
1−
(
S*
S
)q)
− δI*
(
S
S*
)q ((S*
S
)q
− 1
)2
+ δI*
(
1−
(
I*
I
)p)(( I
I*
)p
− I
I*
)
.
Thus we have
V˙ (S, I) = µS*
(
1− S
S*
)(
1−
(
S*
S
)q)
− δI*
(
S
S*
)q ((S*
S
)q
− 1
)2
+ δI*
(
1−
(
I*
I
)p)(( I
I*
)p
− I
I*
)
≤ 0, ∀p < 1.
(3.16)
Therefore, as explained by Korobeinikov and Maini [11], the condition p < 1 ensures that dVdt ≤ 0 for all
S, I > 0, where the equality holds only at the equilibrium point Q*=(S*,I*) as defined in (3.13). By the
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Lyapunov asymptotic stability theorem 1.3.3, the equilibrium point Q* is globally asymptotically stable.
This result is valid for the whole of R2+.
3.3.2 An SIR Model Given by Korobeinikov and Maini [12]
The second SIR model we will concentrate on is also a model with nonlinear incidence.
We consider, as in [12], a function f(S, I,N), where
f(S, 0, N) = f(0, I,N) = 0 (3.17)
and
∂f(S, I,N)
∂I
> 0,
∂f(S, I,N)
∂S
> 0, (3.18)
holds for all S, I > 0 and we also assume that the function f(S, I,N) is concave with respect to the variable
I, i.e.
∂2f(S, I,N)
∂I2
≤ 0, for all S, I > 0. (3.19)
For the incidence rate of the form h(S)g(I) satisfying the conditions (3.17)-(3.18), the direct Lyapunov
method enables us to prove global stability for some models. Korobeinikov and Maini [12] claims that the
direct Lyapunov method so far is the most effective method of global analysis.
The basic SIR model is given by Korobeinikov and Maini [12] as:
S˙ = µ− h(S)g(I)− µS,
I˙ = h(S)g(I)− (δ + µ)I. (3.20)
Here the equation for the recovered population R is omitted, and as usual we assume that the incidence
rate satisfies the conditions (3.17)-(3.19). The condition (3.19) ensures this systems has two equilibrium
states: an infection-free equilibrium Q0 and an endemic equilibrium Q*.
Finding the infection-free equilibrium:
Infection-free⇒ I0 = 0.
We need to find S0 such that S˙ = 0:
⇒ S˙ = µ− h(S0)g(I0)− µS0 = 0
⇒ µ− h(S0)g(0)− µS0 = 0
⇒ µ− µS0 = 0
⇒ µS0 = µ
⇒ S0 = 1.
Thus we have an infection-free equilibrium Q0 = (1, 0).
Finding the endemic equilibrium:
First we consider I˙ = 0:
I˙ = h(S*)g(I*)− (δ + µ)I* = 0
⇒ (δ + µ)I* = h(S*)g(I*).
Now considering S˙ = 0:
S˙ = µ− h(S*)g(I*)− µS* = 0
⇒ µS* + h(S*)g(I*) = µ.
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Substituting in (δ + µ)I* = h(S*)g(I*):
µS* + (δ + µ)I* = µ.
Thus we have an endemic equilibrium Q*= (S*, I*), such that
(δ + µ)I* = h(S*)g(I*), µS* + (δ + µ)I* = µ. (3.21)
For this SIR model, Korobeinikov and Maini [12] give the possible Lyapunov function:
V (S, I) = S − h(S*)
∫ S
a
dτ
h(τ)
+
(
I − g(I*)
∫ I
a
dτ
g(τ)
)
. (3.22)
Here the parameter a, such that 0 < a  1, is an arbitrary positive constant which is not fixed and can
be made sufficiently small. The function V (S, I) is defined and continuous for all S, I ≥ a and satisfies
∂V
∂S
= 1− h(S*)
h(S)
, and
∂V
∂I
= B
(
1− g(I*)
g(I)
)
.
Since the function h(S) and g(I) grow monotonically, the partial derivatives ∂V∂S and
∂V
∂I grow monotonically
as well. Note that for this function we have ∂V∂S =
∂V
∂I = 0 at Q*, as defined in (3.21), and thus we can
determine the type of equilibrium point. For the possible Lyapunov function (3.22) we can derive the
second derivatives as follows:
∂2V
∂S2
=
h(S*)
(h(S))2
∂h(S)
∂S
> 0,
∂2V
∂I2
=
g(I*)
(g(I))2
∂g(I)
∂I
> 0, and
∂2V
∂S∂I
= 0.
Thus, by the second derivative test, see definition 3.2.3, we can conclude that the endemic equilibrium
state Q*= (S*, I*) is the only local stationary point of the function and is a minimum extreme point.
As V (S, I) → ∞ at the boundary, we have V (S, I) ≥ V (S*, I*) and thus the function is bounded from
below. Consequently Q* is the only extremum and the global minimum of the function in R2+ and hence
the function (3.22) is indeed a Lyapunov function.
The following theorem, given by Korobeinikov and Maini [12], provides global properties of the system
(3.20).
Theorem 3.3.2
1. If the incidence rate satisfies the conditions (3.17)-(3.19), and if R0 > 1, then the endemic equilibrium
state Q* is globally asymptotically stable.
2. If R0 ≤ 1, then there is no positive equilibrium state Q*, and the infection-free equilibrium state Q0
is globally asymptotically stable.
Proof of 1. Using the equalities
(δ + µ)I* = h(S*)g(I*), µ = µS* + (δ + µ)I*, (3.23)
for the equilibrium state Q*, the Lyapunov function V (S, I) satisfies
dV (S, I)
dt
=
(
1− h(S*)
h(S)
)
(µ− h(S)g(I)− µS) +
(
1− g(I*)
g(I)
)
(h(S)g(I)− (δ + µ)I)
= µ− h(S)g(I)− µS − µh(S*)
h(S)
+ g(I)h(S*) + µS
h(S*)
h(S)
+ h(S)g(I)− (δ + µ)I − g(I*)h(S) + (δ + µ)I g(I*)
g(I)
.
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Using the relations (3.23) we get:
dV (S, I)
dt
= [µS* + (δ + µ)I*]− µS* S
S*
− [µS* + (δ + µ)I*] h(S*
h(S)
+ (δ + µ)I*
g(I)
g(I*)
+ µS
h(S*)
h(S)
− (δ + µ)I − (δ + µ)I* h(S)
h(S*)
+ (δ + µ)I
g(I*)
g(I)
= (δ + µ)I*
(
1− h(S*)
h(S)
− h(S)
h(S*)
)
+ µS*
(
1− h(S*)
h(S)
− S
S*
+
S
S*
h(S*)
h(S)
)
+ (δ + µ)I*
(
I
I*
g(I*)
g(I)
+
g(I)
g(I*)
− I
I*
)
= (δ + µ)I*
(
2− h(S*)
h(S)
− h(S)
h(S*)
)
+ µS*
(
1− h(S*)
h(S)
− S
S*
+
S
S*
h(S*)
h(S)
)
+ (δ + µ)I*
(
I
I*
g(I*)
g(I)
+
g(I)
g(I*)
− I
I*
− 1
)
= −(δ + µ)I*h(S*)
h(S)
(
1− 2 h(S)
h(S*)
+
(
h(S)
h(S*)
)2)
+ µS*
(
1− h(S*)
h(S)
− S
S*
+
S
S*
h(S*)
h(S)
)
− (δ + µ)I*
(
1− I
I*
g(I*)
g(I)
− g(I)
g(I*)
+
I
I*
− 1
)
,
which can be rearranged to give:
dV (S, I)
dt
= −(δ + µ)I*h(S*)
h(S)
(
1− 2 h(S)
h(S*)
)2
+ µS*
(
1− S
S*)
)(
1− h(S*)
h(S)
)
− (δ + µ)I*
(
g(I*)
g(I)
− 1
)(
g(I)
g(I*)
− I
I*
)
.
Thus we have
dV (S, I)
dt
= −(δ + µ)I*h(S*)
h(S)
(
1− 2 h(S)
h(S*)
)2
+ µS*
(
1− S
S*)
)(
1− h(S*)
h(S)
)
− (δ + µ)I*
(
g(I*)
g(I)
− 1
)(
g(I)
g(I*)
− I
I*
)
≤ 0, for all S, I > a.
(3.24)
Hence the endemic equilibrium state is globally asymptotically stable.
Proof of 2. To prove global stability of the infection-free equilibrium state Q0 = (1, 0) we consider, as in
[12], the Lyapunov test function:
U(S, I) = S − h(S0)
∫ S
a
dτ
h(τ)
+ I.
For system (3.20), the Lyapunov function satisfies
dU(S, I)
dt
=
(
1− h(S0)
h(S)
)
(µ− h(S)g(I)− µS) + (1) (h(S)g(I)− (δ + µ)I)
= µ− h(S)g(I)− µS − µh(S0)
h(S)
+ h(S0)g(I) + µS
h(S0)
h(S)
+ h(S)g(I)− (δ + µ)I
= µ
(
1− h(S0)
h(S)
− S + Sh(S0
h(S)
)
+ h(S0)g(I)− (δ + µ)I
= µ(1− S)
(
1− h(S0)
h(S)
)
+ (δ + µ)I
(
h(S0)
δ + µ
g(I)
I
− 1
)
.
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Here
(1− S)
(
1− h(S0)
h(S)
)
≤ 0, for all S > 0,
and the conditions (3.17) and (3.19) ensure that g(I)I ≤ ∂g(0)∂I , for all I > 0. Hence, as given by Korobeinikov
and Maini [12], using
R0 =
θ
(θ + µ)(δ + µ)
∂f(S0, I0, N)
∂I
, (3.25)
we have
h(S0)
δ + µ
g(I)
I
≤ h(S0)
δ + µ
∂g(0)
∂I
= R0.
Therefore, R0 ≤ 1 ensures that dVdt ≤ 0, for all S, I > a, and hence by the asymptotic stability theorem
(see theorem 1.3.3), the equilibrium state Q0 is globally asymptotically stable in this case. The theorem is
proven.
3.3.3 An SIR Model Given by Korobeinikov [10]
The final SIR model we will concentrate on is also a model with nonlinear incidence. This paper attempts
to extend the Lyapunov functions constructed by Korobeinikov and Maini [12] to a more general incidence
rate given by an arbitrary function f(S, I).
The basic SIR model is given by Korobeinikov [10] as:
S˙ = µ− f(S, I)− µS,
I˙ = f(S, I)− δI. (3.26)
Here µ is the death/birth rate and δ is the sum of the death rate of infected individuals (which is here
assumed to be equal to the death rate of susceptibles) and the recovery rate. The equation for the recovery
population, which in this case is
R˙ = (δ − µ) I − µR,
is usually omitted-the constant population size assumption enables us to do that.
Korobeinikov [10] explains that f(S, I) is a positive and monotonically growing function for all S, I > 0,
and f(0, I) = f(S, 0) = 0. These conditions solely arise from biological considerations; further we will show
that they are not necessary for our analysis.
It is easy to see that the non-negative quadrant of the SI plane is an invariant set of the system. The
system has two equilibrium states: an infection-free equilibrium and an endemic equilibrium.
Finding the infection-free equilibrium:
Infection-free ⇒ I0 = 0.
We need to find S0 such that S˙ = 0:
S˙ = µ− f(S0, I0)− µS0 = 0
⇒ µ− f(S0, 0)− µS0 = 0
⇒ µ− (0)− µS0 = 0
⇒ µ− µS0 = 0
⇒ µS0 = µ
⇒ S0 = 1.
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Thus we have an infection-free equilibriumQ0 with the coordinates S0 = 1, I0 = 0.
Finding the endemic equilibrium:
First we will consider S˙ = 0:
S˙ = µ− f(S*, I*)− µS* = 0
⇒ µ = f(S*, I*) + µS*.
Next we will consider I˙ = 0:
I˙ = f(S*, I*)− δI*
⇒ δI* = f(S*, I*).
Thus we have an endemic equilibrium Q*=(S*,I*), such that
µ = f(S*, I*) + µS* and δI* = f(S*, I*). (3.27)
By the following theorem given by Korobeinikov [10], we will show that, under certain biologically reason-
able conditions, if the function f(S, I) is concave with respect to the variable I (that is if ∂
2f
∂I2
≤ 0 holds
for all I > 0), then the uniqueness of the equilibrium state Q* is ensured.
For this model, the basic reproduction number is
R0 =
1
δ
∂f(S0, I0)
∂I
.
Theorem 3.3.3
1. Assume that the function f(S, I) monotonically grows with respect to S and I and is concave with
respect to the variable I (that is if ∂
2f
∂I2
≤ 0). Assume also R0 > 1, then the system (3.26) has
an unique positive endemic equilibrium state Q*= (S*, I*), as defined in (3.27), which is globally
asymptotically stable.
2. If R0 ≤ 1, then there is no positive endemic equilibrium state, and the infection-free equilibrium state
Q0 is globally asymptotically stable.
Proof: Existence of a positive equilibrium state. Korobeinikov [10] explains that at a fixed point of the
system the relations δI + µS = µ and δI = f(S, I) hold. These equalities define a negatively sloped
straight line q1 and a curve q2 on the IS plane (Figure 3.2). The equality δI = f(S, I) defines also a
function S = h(I). If ∂f(S,I)∂S is strictly positive, then, by the implicit function theorem, the function h(I)
is defined and continuous for all I > 0. It is obvious (see Figure 3.2) that if S* = h(0) ≤ S0 = 1 then there
is at least one point of intersection of the lines q1 and q2. The function f(S, I) grows monotonically with
respect to both its variables, and hence
S0
S*
> 1 if
lim
I→0
f(S0, I)
f(S*, I)
= lim
I→0
f(S0, I)
δI
=
1
δ
∂f(S0, 0)
∂I
= R0 > 1.
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S
I
S0
S∗
q1
q2
Figure 3.2: The straight line q1 and the curve q2.
Proof: Stability of the endemic equilibrium state. We assume that R0 > 1, and hence there exists a positive
endemic equilibrium state Q*= (S*, I*), as defined in (3.27). The function, given be Korobeinikov [10]:
V (S, I) = S −
∫ S
ε
f(S*, I*)
f(τ, I*)
dτ + I −
∫ I
ε
f(S*, I*)
f(S*, τ)
dτ, (3.28)
is defined and continuous for all S, I > ε and satisfies
∂V
∂S
= 1− f(S*, I*)
f(S, I*)
and
∂V
∂I
= 1− f(S*, I*)
f(S*, I)
. (3.29)
Since the function f(S, I) is monotonic with respect to both variables, the partial derivatives ∂V∂S and
∂V
∂I
are also monotonic. Note that for this function we have ∂V∂S =
∂V
∂I = 0 at Q*= (S*, I*), as defined in (3.27),
and thus we can determine the type of equilibrium point. For the possible Lyapunov function (3.28) we
can derive the second derivatives as follows:
∂2V
∂S2
=
f(S*, I*)
(f(S, I*))2
∂f(S, I*)
∂S
> 0,
∂2V
∂I2
=
f(S*, I*)
(f(S*, I))2
∂f(S*, I)
∂I
> 0 and
∂2V
∂S∂I
= 0.
Thus, by the second derivative test, see definition 3.2.3, we can conclude that if f(S, I) is monotonic
with respect to both variables then the endemic equilibrium state Q*= (S*, I*) is the only local station-
ary point of the function and is a minimum extreme point. As V (S, I) → ∞ at the boundary, we have
V (S, I) ≥ V (S*, I*) and thus the function is bounded from below. Consequently Q* is the only extremum
and the global minimum of the function in R2+ and hence the function (3.28) is indeed a Lyapunov function.
In the case of system (3.26), using
µ = f(S*, I*) + µS* and δI* = f(S*, I*)
the Lyapunov function (3.28) satisfies
dV (S, I)
dt
=
(
1− f(S*, I*)
f(S, I*)
)
(µ− f(S, I)− µS) +
(
1− f(S*, I*)
f(S*, I)
)
(f(S, I)− δI),
which can be rearranged to give:
dV (S, I)
dt
= µ− f(S, I)− µS − µf(S*, I*)
f(S, I*)
+
f(S*, I*)
f(S, I*)
f(S, I)
+ µS
f(S*, I*)
f(S, I*)
+ f(S, I)− δI − f(S*, I*)
f(S*, I)
f(S, I) + δI
f(S*, I*)
f(S*, I)
.
Also note that we have µ = f(S*, I*) + µS* and δI* = f(S*, I*)⇒ δ = 1
I*
f(S*, I*).
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Substituting in:
dV (S, I)
dt
= (f(S*, I*) + µS*)− µS − (f(S*, I*) + µS*) f(S*, I*)
f(S, I*)
+
f(S, I)
f(S*, I)
f(S*, I*)
+ µS
f(S*, I*)
f(S*, I)
−
(
1
I*
f(S*, I*)
)
I − f(S, I)
f(S*, I)
f(S*, I*) +
(
1
I*
f(S*, I*)
)
I
f(S*, I*)
f(S*, I)
= f(S*, I*) + µS*− µS − f(S*, I*)
f(S*, I)
f(S*, I*)− µS*f(S*, I*)
f(S, I*)
+
f(S, I)
f(S, I*)
f(S*, I*)
+ µS
f(S*, I*)
f(S, I*)
− I
I*
f(S*, I*)− f(S, I)
f(S*, I)
f(S*, I*) +
I
I*
f(S*, I*)
f(S*, I)
f(S*, I*)
= µS*
(
1− S
S*
− f(S*, I*)
f(S, I*)
+
S
S*
f(S*, I*)
f(S, I*)
)
+ f(S*, I*)
(
1− f(S*, I*)
f(S, I*)
+
f(S, I)
f(S, I*)
− I
I*
− f(S, I)
f(S*, I)
+
I
I*
f(S*, I*)
f(S*, I)
)
,
which via rearrangement gives:
dV (S, I)
dt
= µS*
(
1− S
S*
− f(S*, I*)
f(S, I*)
+
S
S*
f(S*, I*)
f(S, I*)
)
+ f(S*, I*)
(
1− f(S*, I*)
f(S, I*)
− f(S, I)
f(S*, I)
)
+ f(S*, I*)
(
− I
I*
+
f(S, I)
f(S, I*)
+
I
I*
f(S*, I*)
f(S*, I)
)
= µS*
(
1− S
S*
)(
1− f(S*, I*)
f(S, I*)
)
+ f(S*, I*)
(
1− f(S*, I*)
f(S, I*)
)(
1− f(S, I)
f(S*, I)
)
+ f(S*, I*)
(
I
I*
− f(S, I)
f(S, I*)
)(
f(S*, I*)
f(S*, I)
− 1
)
.
If Q*>0 and the function f(S, I) is concave with respect to I, then dVdt ≤ 0 for all S, I > 0. Indeed, the
monotonicity of f(S, I) with respect to S ensures that(
1− S
S*
)(
1− f(S*, I*)
f(S, I*)
)
≤ 0
and (
1− f(S*, I*)
f(S, I*)
)(
1− f(S, I)
f(S*, I)
)
≤ 0
hold for all S, I > 0 (see also [10]). Furthermore(
I
I*
− f(S, I)
f(S, I*)
)(
f(S*, I*)
f(S*, I)
− 1
)
≤ 0
if
I
I*
≤ f(S, I)
f(S, I*)
when f(S*, I*) ≥ f(S*, I), and
I
I*
≥ f(S, I)
f(S, I*)
when f(S*, I*) ≤ f(S*, I)
(3.30)
holds for all S, I > 0. For a monotonic function, f(S*, I) ≥ f(S*, I*) implies I ≥ I*, and f(S*, I) ≤
f(S*, I*) implies I ≤ I*, and hence the condition (3.30) is equivalent to the condition
f(S, I)
f(S, I*
≥ I
I*
for all I ≤ I*, and
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f(S, I)
f(S, I*)
≤ I
I*
for all I ≥ I*.
This condition (and hence condition (3.30)) holds for all functions concave with respect to the variable I
(see Figure 3.3), and hence the concavity is sufficient to ensure that dV (S,I)dt ≤ 0 in R2+ (see also [10]).
I
I*
I*
f(S,I)
f(S,I*)
Figure 3.3: A function f(S, I) concave with respect to I.
Proof: Uniqueness of the positive endemic equilibrium state. Following the work of Korobeinikov [10],
we now assume that apart from the equilibrium Q*, the system has another positive equilibrium state
Q1 = (S1, I1). Then, substituting S1 and I1 into the equalities (3.27), we derive f(S1, I1) + µS1 = µ and
δI1 = f(S1, I1).
The derivative of a Lyapunov function is equal to zero at any equilibrium state, and therefore dVdt = 0
at Q1. Therefore, S1 and I1 must satisfy the equalities(
1− S1
S*
)(
1− f(S*, I*)
f(S1, I*)
)
= 0, (3.31)(
1− f(S*, I*)
f(S1, I*)
)(
1− f(S1, I)
f(S*, I)
)
= 0, (3.32)(
I1
I*
− f(S1, I1)
f(S1, I*)
)(
f(S*, I*)
f(S*, I1)
− 1
)
= 0. (3.33)
It is obvious that for a monotonic function (or a function satisfying condition (3.29)), the equality (3.31)
holds only when S1 = S*. Then I1 = I* is necessary to satisfy f(S*, I1) + µS*= µ. That is S1 = S*
and I1 = I*, and hence Q* is the only positive fixed point of the system. For a monotonic function (or
satisfying condition (3.29)), the point Q* is the only invariant set (see definition 1.4.1) of the system (3.26)
in the set dVdt = 0 (see also [10]) and therefore, by LaSalle’s invariance principle (see theorem 1.4.1), the
point Q* is asymptotically stable for all S ≥ ε.
Note that the parameter ε may be made as small as required, and therefore the endemic equilibrium
Q* is asymptotically stable in the non-negative quadrant R2+.
Proof: Stability of the infection free equilibrium state. To prove the global stability of the infection-free
equilibrium state Q0 = (1, 0) we consider the potential Lyapunov function, given by Korobeinikov [10]:
U(S, I) = S −
∫ S
ε
lim
I→I0
f(S0, I)
f(τ, I)
dτ + I.
Note that here we cannot consider the function U(S, I) = S − ∫ Sε f(S0,I)f(τ,I) dτ + I, because f(S, 0) = 0. This
Lyapunov function satisfies
dU(S, I)
dt
=
(
1− lim
I→I0
f(S0, I)
f(S, I)
)
(µ− f(S, I)− µS) + (1) (f(S, I)− δI) ,
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which can be rearranged to give:
dU(S, I)
dt
= µ− f(S, I)− µS − µ lim
I→I0
f(S0, I0)
f(S, I0)
+ f(S, I) lim
I→I0
f(S0, I0)
f(S, I0)
+ µS lim
I→I0
f(S0, I0)
f(S, I0)
+ f(S, I)− δI.
As S0 = 1 we can substitute in S =
S
S0
to make simplifying the equations later easier. This then gives the
equation, see also [10]:
dU(S, I)
dt
= µ− µ S
S0
− µ lim
I→I0
f(S0, I0)
f(S, I0)
+ f(S, I) lim
I→I0
f(S0, I0)
f(S, I0)
+ µ
S
S0
lim
I→I0
f(S0, I0)
f(S, I0)
− δI
= µ
(
1− S
S0
− lim
I→I0
f(S0, I0)
f(S, I0)
+
S
S0
lim
I→I0
f(S0, I0)
f(S, I0)
)
+ f(S, I) lim
I→I0
f(S0, I0)
f(S, I0)
− δI
= µ
(
1− S
S0
)(
1− lim
I→I0
f(S0, I0)
f(S, I0)
)
+ δI
(
f(S, I)
δI
lim
I→I0
f(S0, I0)
f(S, I0)
− 1
)
.
For a monotonic function (
1− S
S0
)(
1− lim
I→I0
f(S0, I0)
f(S, I0)
)
≤ 0 for all S > 0,
and concavity of the function f(S, I) ensures that f(S, I) ≤ I ∂f(S,0)∂I for all I > 0, and hence
f(S, I)
δI
lim
I→I0
f(S0), I)
f(S, I)
=
f(S, I)
δI
∂f(S0,I0)
∂I
∂f(S,I0)
∂I
≤ 1
δ
∂f(S0, I0)
∂I
= R0.
Therefore R0 ≤ 1 ensures that dU(S,I)dt ≤ 0 for all S, I > ε (see also [10]), and hence by the asymptotic
stability theorem (see theorem ??) the equilibrium state Q0 is globally asymptotically stable in this case.
Therefore, as also concluded by Korobeinikov [10], for all R0 > 1 there exists an unique and globally stable
positive equilibrium state Q*, and that for R0 < 1 the infection-free equilibrium Q0 is globally stable. At
R0 = 1 for any function f(S, I) monotonic with respect to S the point at which the two equilibria, Q0
and Q*, meet is a transcritical bifurcation point i.e., at this point the equilibrium points exchange their
stability. Indeed for a monotonic function f(S, I), S* (and hence S*) tends to S0 as R0 tends to 1 (see also
[10]), and that R0 = 1 implies S* = S0. At R0 = 1 the point (S0, I0) is, therefore, the point of intersection
of the lines q1 and q2 (see Figure 3.3). For R0 > 1 the equilibrium Q* moves in the quadrant S > 0, I < 0.
The theorem is proven.
3.4 SIS Models
Some infections (e.g., gonorrhea) do not give rise to acquired immunity in the host and so the third type
of epidemiological model we will concentrate on is the SIS model. Here we divide the population, of size
N , into the subpopulations defined in (3.1) however for this model we do not require the removed R(t)
compartment . For the SIS model, we assume that an individual begins in the susceptibles compartment,
after infection moves to the infective compartment and once the individual has recovered, we assume no
immunity, and thus the individual will return to the susceptibles compartment. We will again also assume
that the population size N = S + I is constant, therefore implying that deaths are balanced by births.
3.4.1 An SIS Model Given by Korobeinikov and Wake [13]
Note that the SIS model, as also commented by Korobeinikov and Wake [13], can be regarded as the
limiting case of the SIRS model with no period of immunity. For example, using system (3.1) we would
let
1
α
→ 0 which would enable us to produce an SIS model.
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Korobeinikov and Wake [13] considers the SIS model with vertical transmission (see Figure 3.4) with the
differential equations:
S˙ = γN − βSI
N
− pγI + δI − σS,
I˙ = β
SI
N
− (δ + σ + ε− pγ)I,
(3.34)
where δ is the rate of recovery, σ and ε are the rates of natural and disease-associated mortality and other
parameters are the same as for the SIRS system (3.1). We again assume that the population size N is
constant.
γ(NpI)
S
σS
β SI
N
I
γpI
σI
δI
S
Figure 3.4: Transfer diagram of the SIS model (3.34) given by Korobeinikov and Wake [13].
The system has two equilibria: an infection-free equilibrium state and an endemic equilibrium state.
Finding the infection-free equilibrium:
Infection-free ⇒ I0 = 0.
We need to find S0 such that S˙ = 0:
S˙ = γN − βS0I0
N
− pγI0 + δI0 − σS0 = 0
⇒ γN − βS0(0)
N
− pγ(0) + δ(0)− σS0 = 0
⇒ γN − σS0 = 0
⇒ σS0 = γN
⇒ S0 = γN
σ
.
Thus we have an infection-free equilibrium state E0 = (
γN
σ , 0).
Next we will find the endemic equilibrium.
First we need to find S* such that I˙ = 0:
I˙ = β
S*I*
N
− (δ + σ + ε− pγ)I* = 0
⇒ βS*I*
N
= (δ + σ + ε− pγ)I*
⇒ S* = (δ + σ + ε− pγ)N
β
=
γ
σ
(
σ(δ + σ + ε− pγ)
βγ
)
N
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=
γ
σ
N
R0
where R0 =
βγ
σ(δ + σ + ε− pγ) .
Next we need to find I* such that S˙ = 0:
S˙ = γN − βS*I*
N
− pγI* + δI*− σS* = 0
⇒ βS*I*
N
+ pγI*− δI* = γN − σS*
⇒ I*
(
βS*
N
+ pγ − δ
)
= γN − σS*
⇒ I* = γN − σS*
βS*
N + pγ − δ
.
Substituting in S* =
γ
σ
N
R0
=
(δ + σ + ε− pγ)N
β
:
I* =
γN − σ (δ+σ+ε−pγ)Nβ
β
N
(
(δ+σ+ε−pγ)N
β
)
+ pγ − δ
=
(
βγ − σ(δ + σ + ε− pγ)
β(δ + σ + ε− pγ + pγ − δ)
)
N
=
(
βγ − σ(δ + σ + ε− pγ)
β(σ + ε)
)
N
=
γ
σ + ε
(
βγ − σ(δ + σ + ε− pγ)
βγ
)
N
=
γ
σ + ε
(
1− σ(δ + σ + ε− pγ)
βγ
)
N
=
γ
σ + ε
(
1− 1
R0
)
N
where R0 =
βγ
σ(δ + σ + ε− pγ) .
Thus we have an endemic equilibrium E* = (S*, I*), with
S* =
γ
σ
N
R0
and I* =
γ
σ + ε
(
1− 1
R0
)
N, (3.35)
where R0 =
βγ
σ(δ + σ + ε− pγ) . The positive endemic equilibrium exists if R0 > 1.
Note that, using
S* =
(δ + σ + ε− pγ)N
β
and I* =
(
βγ − σ(δ + σ + ε− pγ)
β(σ + ε)
)
N,
we have
β
S*I*
N
=
β
N
(
(δ + σ + ε− pγ)N
β
)
I* = (δ + σ + ε− pγ)I*
and
γN + (δ − pγ)I*− σS* = γN + (δ − pγ)
(
βγ − σ(δ + σ + ε− pγ)
β(σ + ε)
)
N − σ
(
(δ + σ + ε− pγ)N
β
)
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=
βγN(σ + ε) + (δ − pγ)(βγ − σ(δ + σ + ε− pγ))N − σ(δ + σ + ε− pγ)N(σ + ε)
β(σ + ε)
=
N(σ + ε)(βγ − σ(δ + σ + ε− pγ)) + (δ − pγ)(βγ − σ(δ + σ + ε− pγ))N
β(σ + ε)
=
(
(δ + σ + ε− pγ)(βγ − σ(δ + σ + ε− pγ))
β(σ + ε)
)
N
= (δ + σ + ε− pγ)
[(
βγ − σ(δ + σ + ε− pγ)
β(σ + ε)
)
N
]
= (δ + σ + ε− pγ)I*.
Thus we have
β
S*I*
N
= γN + (δ − pγ)I*− σS* = (δ + σ + ε− pγ)I*. (3.36)
After a small alteration, the Lyapunov function (3.5) can be applied to system (3.34) and we can therefore
derive the following, as given by Korobeinikov and Wake [13].
Theorem 3.4.1 The endemic equilibrium state E*=(S*, I*) of system (3.34) is globally stable.
Proof. We consider the potential Lyapunov function
U(S, I) = S*
(
S
S*
− ln S
S*
)
+
σ + ε
δ + σ + ε− pγ I*
(
I
I*
− ln I
I*
)
, (3.37)
which is a modification of function (3.5). This function is defined and continuous for all S, I > 0 and
satisfies
∂U
∂S
= 1− S*
S
and
∂U
∂I
=
σ + ε
δ + σ + ε− pγ
(
1− I*
I
)
.
Note that for this function we have ∂U∂S =
∂U
∂I = 0 at E*, as defined in (3.35), and thus we can determine the
type of equilibrium point. For the possible Lyapunov function (3.37) we can derive the second derivatives
as follows:
∂2U
∂S2
=
S*
S2
> 0,
∂2U
∂I2
=
(
σ + ε
δ + σ + ε− pγ
)
I*
I2
> 0 and
∂2U
∂S∂I
= 0.
Thus, by the second derivative test, see definition 3.2.3, we can conclude that the endemic equilibrium
state E*= (S*, I*) is the only local stationary point of the function and is a minimum extreme point.
As U(S, I) → ∞ at the boundary, we have U(S, I) ≥ U(S*, I*) and thus the function is bounded from
below. Consequently E* is the only extremum and the global minimum of the function in R2+ and hence
the function (3.37) is indeed a Lyapunov function.
In the case of system (3.34), using (3.36), the derivative of the function satisfies:
U˙(S, I) =
(
1− S*
S
)(
γN − βSI
N
− pγI + δI − σS
)
+
σ + ε
δ + σ + ε− pγ
(
1− I*
I
)(
β
SI
N
− (δ + σ + ε− pγ)I
)
= γN − βSI
N
− pγI + δI − σS − γN S*
S
+ β
S*
N
I + pγ
S*
S
I − δS*
S
I + σS*
+
σ + ε
δ + σ + ε− pγ
(
β
SI
N
− (δ + σ + ε− pγ)I − βSI*
N
+ (δ + σ + ε− pγ)I*
)
= γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I + (pγ − δ)S*
S
I + σS*
+
σ + ε
δ + σ + ε− pγ
(
β
SI
N
− βSI*
N
)
+
σ + ε
δ + σ + ε− pγ [(I*− I)(δ + σ + ε− pγ)] .
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Which can be rearranged to give:
U˙(S, I) = γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I − (δ − pγ)S*
S
I + σS*
+
σ + ε
δ + σ + ε− pγ
(
β
SI
N
− β I*
N
S
)
+ (σ + ε)(I − I*).
Note that we have:
γN + (δ − pγ)I*− σS* = (δ + σ + ε− pγ)I*
⇒ σS* = γN + (δ − pγ)I*− (δ + σ + ε− pγ)I* = γN − (σ + ε)I*.
Then we have:
U˙(S, I) = γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I − (δ − pγ)S*
S
I + γN − (σ + ε)I*
+
σ + ε
δ + σ + ε− pγ
(
β
SI
N
− β I*
N
S
)
− (σ + ε)(I − I*)
= 2γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I − (δ − pγ)S*
S
I
+
σ + ε
δ + σ + ε− pγ
(
β
SI
N
− β I*
N
S
)
− (σ + ε)I.
Note that:
β
S*I*
N
= (δ + σ + ε− pγ)I*⇒ βS*
N
= (δ + σ + ε− pγ)⇒ σ + ε = βS*
N
− (δ − pγ).
Then we have
U˙(S, I) = 2γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I − (δ − pγ)S*
S
I
+
[(
β
S*
N
− (δ − pγ)
)(
N
βS*
)](
β
SI
N
− β I*
N
S
)
−
(
β
S*
N
− (δ − pγ)
)
I
= 2γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I − (δ − pγ)S*
S
I
+
[(
β
S*
N
− (δ − pγ)
)(
S
S*
I − S
S*
I*
)]
−
(
β
S*
N
− (δ − pγ)
)
I
= 2γN − βSI
N
+ (δ − pγ)I − σS − γN S*
S
+ β
S*
N
I − (δ − pγ)S*
S
I
+ β
SI
N
− β S
N
I*− (δ − pγ) S
S*
I + (δ − pγ) S
S*
I*− βS*
N
I + (δ − pγ)I
= 2γN + 2(δ − pγ)I − σS − γN S*
S
− (δ − pγ)S*
S
I − β S
N
I*− (δ − pγ) S
S*
I + (δ − pγ) S
S*
I*.
Since
β
S*I*
N
= γN + (δ − pγ)I*− σS*
⇒ σS* = γN + (δ − pγ)I*− βS*I*
N
⇒ σS = γN S
S*
+ (δ − pγ) S
S*
I*− β S
N
I*.
Then we have:
U˙(S, I) = 2γN + 2(δ − pγ)I − γN S
S*
− (δ − pγ)S
I
*S* + β
S
N
I*
− γN S*
S
− (δ − pγ)S*
S
I − β S
N
I*− (δ − pγ) S
S*
I + (δ − pγ) S
S*
I*
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= 2γN − γN S
S*
− γN S*
S
+ 2(δ − pγ)I − (δ − pγ) S
S*
I − (δ − pγ)S*
S
I
Which can be rearranged, as also shown by Korobeinikov and Wake [13], to give:
U˙(S, I) = γN
(
2− S
S*
− S*
S
)
+ (δ − pγ)I
(
2− S
S*
− S*
S
)
= (γN + (δ − pγ)I)
(
2− S
S*
− S*
S
)
= −(γN + (δ − pγ)I) S
S*
((
S*
S
)2
− 2S*
S
+ 1
)
= − (γN + (δ − pγ)I) S
S*
(
1− S*
S
)2
.
Thus we have
U˙(S, I) = − (γN + (δ − pγ)I) S
S*
(
1− S*
S
)2
≤ 0. (3.38)
That is, U˙(S, I) ≤ 0 for all S, I ≥ 0 ensured by δ − pγ ≥ 0. Since U˙(S, I) = 0 holds only for S = S* and
the endemic equilibrium state E* is the only invariant set of the system on the line S = S* (see also [13]),
by the asymptotic stability theorem 1.3.3 the equilibrium state E* is globally asymptotically stable.
As explained in [13], although the case δ − pγ < 0 is hardly biologically feasible, the theorem holds in this
case as well. In this case, an approach also used for the SIRS model in section 3.2, a shift of the system
to the right can be applied.
We will use the substitution (S, I)→ (P, I), where P = S − δ − pγ
β
N ,
Hence we have
P˙ = S˙ = γN − βSI
N
− pγI + δI − σS.
Since
P = S − δ − pγ
β
N ⇒ S = P + δ − pγ
β
N,
we can substitute in to obtain:
P˙ = γN − β I
N
(
P +
δ − pγ
β
N
)
− pγI + δI − σ
(
P +
δ − pγ
β
N
)
= γN − βPI
N
− (δ − pγ)I + (δ − pγ)I − σP − σδ − pγ
β
N
=
(
γ + σ
pγ − δ
β
)
N − βPI
N
− σP
= γˆN − βPI
N
− σP,
where γˆ = γ + σ
pγ − δ
β
.
We will now calculate I˙. We have:
I˙ = β
SI
N
− (δ + σ + ε− pγ)I
and substituting in S = P +
δ − pγ
β
N we obtain:
P˙ = β
I
N
(
P +
δ − pγ
β
N
)
− (δ + σ + ε− pγ)I
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= β
PI
N
+ (δ − pγ)I − (δ + σ + ε− pγ)I
= β
PI
N
− (σ + ε)I.
Thus in the new variables we have:
P˙ = γˆN − βPI
N
− σP, I˙ = βPI
N
− (σ + ε)I, (3.39)
where γˆ = γ + σ
pγ − δ
β
> 0.
In the new variables, the endemic equilibrium can be found as follows:
First we need to find P* such that I˙ = 0:
I˙ = β
P*I*
N
− (σ + ε)I* = 0
⇒ βP*I*
N
= (σ + ε)I*
⇒ P* = σ + ε
β
N.
Next we need to find I* such that P˙ = 0:
P˙ = γˆN − βP*I*
N
− σP* = 0
⇒ βP*I*
N
= γˆN − σP*
⇒ I* =
(
γˆN − σP*
βP*
)
N.
Substituting in P* =
σ + ε
β
N we derive:
I* =
 γˆN − σ
(
σ+ε
β N
)
β
(
σ+ε
β N
)
N
=
 γˆ − σ
(
σ+ε
β
)
σ + ε
N
=
(
βγˆ − σ (σ + ε)
β(σ + ε)
)
N.
Thus the endemic equilibrium state of system (3.39), see also [13], is given by
P* =
σ + ε
β
N, I* =
(
βγˆ − σ (σ + ε)
β(σ + ε)
)
N.
The Lyapunov function (3.5) can therefore be straightforwardly applied to system (3.39). The derivative
of the function satisfies
V˙ (P, I) =
(
1− P*
P
)(
γˆN − βPI
N
− σP
)
+
(
1− I*
I
)(
β
PI
N
− (σ + ε)I
)
,
which can be rearranged to give:
V˙ (P, I) = γˆN − βPI
N
− σP − γˆN P*
P
+ β
P*
N
I + σP* + β
PI
N
− (σ + ε)I − β I*
N
P + (σ + ε)I*
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= γˆN − σP − γˆN P*
P
+ β
P*
N
I + σP*− (σ + ε)I − β I*
N
P + (σ + ε)I*.
Substituting in I* =
(
βγˆ − σ (σ + ε)
β(σ + ε)
)
N we derive:
V˙ (P, I) = γˆN − σP − γˆN P*
P
+ β
P*
N
I + σP*− (σ + ε)I
− β P
N
[(
βγˆ − σ (σ + ε)
β(σ + ε)
)
N
]
+ (σ + ε)
[(
βγˆ − σ (σ + ε)
β(σ + ε)
)
N
]
= γˆN − σP − γˆN P*
P
+ β
P*
N
I + σP*− (σ + ε)I − βγˆ
σ + ε
P + σP + γˆN − σ (σ + ε)
β
N
= 2γˆN − γˆN P*
P
+ β
P*
N
I + σP*− (σ + ε)I − βγˆ
σ + ε
P − σ (σ + ε)
β
N.
Since P* =
σ + ε
β
N ⇒ σ + ε = βP*
N
and
1
P*
=
β
(σ + ε)N
⇒ βγˆ
σ + ε
P = γˆN
P
P*
then:
V˙ (P, I) = 2γˆN − γˆN P*
P
+ β
P*
N
I + σP*− βP*
N
I − γˆN P
P*
− σP*
= 2γˆN − γˆN P*
P
− γˆN P
P*
.
Be rearranging we obtain:
V˙ (P, I) = γˆN
(
2− P
P*
− P*
P
)
= −γˆN P
P*
((
P*
P
)2
− 2P*
P
+ 1
)
= −γˆN P
P*
(
1− P*
P
)2
.
Thus we have
V˙ (P, I) = −γˆN P
P*
(
1− P*
P
)2
≤ 0, for all P, I ≥ 0 (3.40)
Hence, by the asymptotic stability theorem 1.3.3, for the case δ− pγ < 0, the endemic equilibrium state of
system (3.39) and consequently that of system (3.34) is also globally asymptotically stable. The theorem
is proven.
3.5 SEIR Models
The final type of epidemiological model we will concentrate on is the SEIR model. Here we divide the
population, of size N , into the subpopulations defined in (3.1) however for this model we include an
additional compartment E(t) which represents exposed individuals whom have have been infected but are
not yet infectious themselves. For the this model, we assume that an individual begins in the susceptibles
compartment, once exposed to the infection move into the exposed compartment, after becoming infectious
the individual then moves to the infective compartment and then continues into the removed compartment
as a result of recovery, isolation or death by disease. For our SEIR models we assume that recovery
implies permanent immunity. For simplicity, we will again normalize the population size N to 1; i.e. now
S +E + I +R = 1 holds. Our investigation in the current section is based on [11] and [12] and focuses on
the effect of the nonlinear incidence on the global stability of SEIR models.
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3.5.1 An SEIR Model Given by Korobeinikov and Maini [11]
Continuing the same method as used in section 3.2 for the work in [11], we will apply the direct Lyapunov
method to consider the global properties of SEIR models with the incidence rate of the form βIpSq for
the particular case p ≤ 1. Korobeinikov and Maini [11] construct a Lyapunov function for models with
bilinear incidence and we will use their approach to show that the condition p ≤ 1 is a sufficient condition
for global stability, and that the global properties of the systems do not depend on the value of q.
For the incidence rate of the form βIpSq, the basic SEIR model is given by Korobeinikov and Maini [11]
as:
S˙ = b− βIpSq − µS,
E˙ = βIpSq − σE
I˙ = θE − δI.
(3.41)
Here b is the birth rate, µ is the susceptible death rate, δ is the infective removal rate (including mortality
rate) and θ is the rate with which the exposed population moves into the infective class; σ ≥ θ includes also
mortality of the exposed individuals. We omit the equations for the recovered population R; the constant
population size assumption enables us to do so.
If 0 < p < 1 holds, then each of these systems has two equilibrium states: an infection-free equilib-
rium and an endemic equilibrium.
Finding the infection-free equilibrium:
Infection-free ⇒ I0 = 0.
First we need to find S0 such that S˙ = 0:
S˙ = b− βIp0Sq0 − µS0 = 0
⇒ b− β(0)pSq0 − µS0 = 0
⇒ b− µS0 = 0
⇒ µS0 = b
⇒ S0 = b
µ
.
Next we need to find E0 such that E˙ = 0:
E˙ = βIp0S
q
0 − σE0 = 0
⇒ β(0)pSq0 − σE0 = 0
⇒ σE0 = 0
E0 = 0.
Thus we have an infection-free equilibrium Q0 with the coordinates S0 =
b
µ
,E0 = I0 = 0.
Finding the endemic equilibrium:
First we will consider I˙ = 0:
I˙ = θE*− δI* = 0
⇒ δI* = θE*. (3.42)
Next we will consider E˙ = 0:
E˙ = β(I*)p(S*)q − σE* = 0
3.5. SEIR MODELS 37
⇒ β(I*)p(S*)q = σE*. (3.43)
Substituting (3.42) into (3.43):
σE* =
σ
θ
δI* = β(I*)p(S*)q. (3.44)
Finally we will consider S˙ = 0:
S˙ = b− β(I*)p(S*)q − µS* = 0
⇒ µS* + β(I*)p(S*)q = b. (3.45)
Substituting (3.44) into (3.45):
µS* +
σ
θ
δI* = b. (3.46)
Thus, using (3.42), (3.44) and (3.46), we have the endemic equilibrium state Q*= (S*, E*, I*), such that
σ
θ
δI* = β(I*)p(S*)q, µS* +
σ
θ
δI* = b, δI* = θE*. (3.47)
We will now consider the following theorem as given by Korobeinikov and Maini [11].
Theorem 3.5.1 If p ≤ 1, then the endemic equilibrium states Q* of the model (3.41) is globally asymp-
totically stable. The stability does not depend on the value of the parameter q.
Proof. Assume that p, q 6= 1. Then for the SEIR model, we consider a test Lyapunov function of the form
V (S,E, I) = S
(
1 +
1
q − 1
(
S*
S
)q)
+BI
(
1 +
1
p− 1
(
I*
I
)p)
+ (E − E* lnE), (3.48)
where B =
σ
θ
. This function is defined and continuous for all S,E, I > 0 and satisfies
∂V
∂S
=
(
1−
(
S*
S
)q)
,
∂V
∂E
=
(
1− E*
E
)
and
∂V
∂I
= B
(
1−
(
I*
I
)p)
.
Note that for this function we have ∂V∂S =
∂V
∂E =
∂V
∂I = 0 at Q*, as defined in (3.47), and thus we can
determine the type of equilibrium point. For the possible Lyapunov function (3.48) we can derive the
second derivatives as follows:
∂2V
∂S2
=
q
S
(
S*
S
)q
> 0,
∂2V
∂E2
=
E*
E2
> 0,
∂2V
∂I2
=
Bp
I
(
I*
I
)p
> 0,
and
∂2V
∂S∂E
=
∂2V
∂S∂I
=
∂2V
∂E∂I
= 0.
Thus, by the second derivative test, see definition 3.2.3, we can conclude that the endemic equilibrium state
Q*= (S*, E*, I*) is the only extremum and the global minimum of the function in the positive octant R3+
and hence V (S,E, I) ≥ V (S*, E*, I*). Consequently, the function (3.48) is indeed a Lyapunov function.
Using
b = µS* +BδI*, β(I*)p(S*)q = BδI*, δI* = θE*, Bθ = σ (3.49)
for the equilibrium state Q*, as defined in (3.47), the Lyapunov function (3.48) satisfies
V˙ (S,E, I) =
(
1−
(
S*
S
)q)
(b− βIpSq − µS) +
(
1− E*
E
)
(βIpSq − σE)
38 CHAPTER 3. EPIDEMIOLOGICAL MODELS
+B
(
1−
(
I*
I
)p)
(θE − δI)
= b− βIpSq − µS − b
(
S*
S
)q
+ βIp(S*)q + µS
(
S*
S
)q
+ βIpSq − σE
− βIpSq
(
E*
E
)
+ σE* +B
[
θE − δI − θE
(
I*
I
)p
+ δI
(
I*
I
)p]
,
Which can be rearranged to give:
V˙ (S,E, I) = b− βIpSq − µS − b(S*)
q
Sq
+ βIp(S*)q + µ
(S*)q
Sq−1
+ βIpSq − σE − βIpSqE*
E
+ σE* +B
(
θE − δI − θ (I*)
p
Ip
E + δ
(I*)p
Ip−1
)
.
Using now relations (3.49) we derive:
V˙ (S,E, I) = µS* +BδI*− µS − (µS* +BδI*) (S*)
q
Sq
+ βIp(S*)q + µ
(S*)q
Sq−1
− σE
− βIpSqE*
E
+ σE* +BθE −BδI −Bθ (I*)
p
Ip
E + δ
(I*)p
Ip−1
.
= µS* +BδI*− µS − µS*(S*)
q
Sq
−BδI*(S*)
q
Sq
+ βIp(S*)q + µ
(S*)q
Sq−1
−Bδ E
E*
I*− βIpSqE*
E
+BδI* +Bδ
E
E*
I*− βI(I*)p−1(S*)q −BδI*(I*)
p
Ip
E
E*
+Bδ
(I*)p
Ip−1
= µS* +BδI*− µS* S
S*
− µS*(S*)
q
Sq
−BδI*(S*)
q
Sq
+BδI*
Ip
(I*)p
+ µS*
(S*)q−1
Sq−1
−BδI*E*
E
Sq
(S*)q
Ip
(I*)p
+BδI*−BδI* I
I*
−BδI* E
E*
(I*)p
Ip
+BδI*
(I*)p−1
Ip−1
.
Rearranging now the latter relation as in [11] we get:
V˙ (S,E, I) = BδI*
(
2− (S*)
q
Sq
+
Ip
(I*)p
− E*
E
Sq
(S*)q
Ip
(I*)p
− I
I*
− E
E*
(I*)p
Ip
+
(
I
I*
)1−p)
+ µS*
(
1− S
S*
− (S*)
q
Sq
+
(
S
S*
)1−q)
.
Let u =
S
S*
, v =
I
I*
and w =
E(I*)p
E*Ip
then:
V˙ (S,E, I) = BδI*
(
2− u−q + vp − u
q
w
− v − w + v1−p
)
+ µS*
(
1− u− u−q + u1−q)
= BδI*
(
vp − v + v1−p − 1)+BδI*(3− u−q − uq
w
− w
)
+ µS*
(
1− u− u−q + u1−q) ,
which under rearrangement gives:
V˙ (S,E, I) = −BδI* (v1−p − 1) (vp − 1) +BδI*(3− u−q − uq
w
− w
)
+ µS* (1− u)
(
1− 1
uq
)
.
If p < 1, then
h(v) = (vp − 1) (v1−p − 1) ≥ 0 for all u,w, q > 0
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where the equality holds only if u = w = 1. Furthermore,
(1− u)
(
1− 1
uq
)
≤ 0 for all u, q > 0.
Therefore, as explained by Korobeinikov and Maini [11], the condition p < 1 ensures that dVdt ≤ 0 for all
S,E, I > 0, where the equality holds only at the equilibrium point Q*=(S*,E*,I*) as defined in (3.47).
By the Lyapunov asymptotic stability theorem 1.3.3, the equilibrium point Q* is globally asymptotically
stable. This result is valid for the whole positive octant R3+.
3.5.2 An SEIR Model Given by Korobeinikov and Maini [12]
Continuing the same method as used in section 3.3 for the work in [12], we will apply the direct Lyapunov
method to consider the global properties of SEIR models with the incidence rate of the form h(S)g(I)
satisfying the conditions (3.17)-(3.18) given in section 3.3. Then the basic SEIR model is given by
Korobeinikov and Maini [12] as:
S˙ = µ− h(S)g(I)− µS,
E˙ = h(S)g(I)− (θ + µ)E,
I˙ = θE − (δ + µ)I.
(3.50)
Here the equations for the recovered population R are omitted, and we note that condition (3.19) ensures
that each of these systems has two equilibrium states: an infection-free equilibrium Q0 and an endemic
equilibrium Q*.
Finding the infection-free equilibrium:
Infection-free⇒ I0 = 0.
We need to find S0 such that S˙ = 0:
S˙ = µ− h(S0)g(I0)− µS0 = 0
⇒ µ− h(S0)g(0)− µS0 = 0
⇒ µ− µS0 = 0
⇒ µS0 = µ
S0 = 1.
Thus we have an infection-free equilibrium Q0 = (1, 0).
Finding the endemic equilibrium:
First we consider I˙ = 0:
I˙ = θE*− (δ + µ)I* = 0
⇒ θE* = (δ + µ)I*
⇒ E* = (δ + µ)
θ
I*.
Now considering E˙ = 0:
E˙ = h(S*)g(I*)− (θ + µ)E* = 0
⇒ (θ + µ)E* = h(S*)g(I*).
Substituting in E* = (δ+µ)θ I*:
⇒ (θ + µ)E* = (θ + µ)
θ
(δ + µ)I*
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and thus:
(θ + µ)
θ
(δ + µ)I* = h(S*)g(I*).
Finally we will consider S˙ = 0:
S˙ = µ− h(S*)g(I*)− µS* = 0
⇒ µS* + h(S*)g(I*) = µ.
Substituting in h(S*)g(I*) = (θ+µ)θ (δ + µ)I*:
µS* +
(θ + µ)
θ
(δ + µ)I* = µ.
Thus we have an endemic equilbrium Q*= (S*, E*, I*), such that
(θ + µ)
θ
(δ + µ)I* = h(S*)g(I*), µS* +
(θ + µ)
θ
(δ + µ)I* = µ,
(θ + µ)
θ
(δ + µ)I* = (θ + µ)E*. (3.51)
For this SEIR model, Korobeinikov and Maini [12] give the possible Lyapunov function:
V (S,E, I) = S − h(S*)
∫ S
a
dτ
h(τ)
+B
(
I − g(I*)
∫ I
a
dτ
g(τ)
)
+ E − E* ln(E). (3.52)
where B = θ+µθ and the parameter a, such that 0 < a  1, is an arbitrary positive constant which is
not fixed and can be made sufficiently small. The function V (S,E, I) is defined and continuous for all
S,E, I ≥ a and satisfies
∂V
∂S
= 1− h(S*)
h(S)
,
∂V
∂E
=
(
1− E*
E
)
,
∂V
∂I
= B
(
1− g(I*)
g(I)
)
.
Since the function h(S) and g(I) grow monotonically, the partial derivatives ∂V∂S and
∂V
∂I grow monotonically
as well. Note that for this function we have ∂V∂S =
∂V
∂E =
∂V
∂I = 0 at Q*, as defined in (3.51), and thus we
can determine the type of equilibrium point. For the possible Lyapunov function (3.52) we can derive the
second derivatives as follows:
∂2V
∂S2
=
h(S*)
(h(S))2
∂h(S)
∂S
> 0,
∂2V
∂E2
=
E*
E2
> 0,
∂2V
∂I2
= B
g(I*)
(g(I))2
∂g(I)
∂I
> 0,
and
∂2V
∂S∂E
=
∂2V
∂S∂I
=
∂2V
∂E∂I
= 0.
Thus, by the second derivative test, see definition 3.2.3, we can conclude that the endemic equilibrium
state Q*= (S*, E*, I*) is the only local stationary point of the function and is a minimum extreme point.
As V (S,E, I)→∞ at the boundary, we have V (S,E, I) ≥ V (S*, E*, I*) and thus the function is bounded
from below. Consequently Q* is the only extremum and the global minimum of the function in the positive
octant R3+ and hence the function (3.52) is indeed a Lyapunov function.
The following theorem, given by Korobeinikov and Maini [12], provides global properties of the system
(3.50).
Theorem 3.5.2
1. If the incidence rate satisfies the conditions (3.17)-(3.19), and if R0 > 1, then the endemic equilibrium
state Q* is globally asymptotically stable.
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2. If R0 ≤ 1, then there is no positive equilibrium state Q*, and the infection-free equilibrium state Q0
is globally asymptotically stable.
Proof of 1. Using the equalities
h(S*)g(I*) = B(δ + µ)I*, µ = µS* +B(δ + µ)I*, (θ + µ)E* =
(θ + µ)
θ
(δ + µ)I*.
where B = θ+µθ . For the equilibrium state Q*, the Lyapunov function V (S,E, I) satisfies
dV (S,E, I)
dt
=
(
1− h(S*
h(S)
)
(µ− h(S)g(I)− µS)
+
(
1− E*
E
)
(h(S)g(I)− (θ + µ)E)
+B
(
1− g(I*)
g(I)
)
(θE − (δ + µ)I) .
Which can be rearranged to give:
dV (S,E, I)
dt
= µ− h(S)g(I)− µS − µh(S*)
h(S)
+ h(S*)g(I) + µS
h(S*)
h(S)
+ h(S)g(I)− (θ + µ)E − h(S)g(I)E*
E
+ (θ + µ)E*
+B
(
θE − (δ + µ)I − θE g(I*)
g(I)
+ (δ + µ)I
g(I*)
g(I)
)
.
Substituting the relation (3.23) we derive:
dV (S,E, I)
dt
= [µS* +B(δ + µ)I*]− µS* S
S*
− [µS* +B(δ + µ)I*] h(S*)
h(S)
+B(δ + µ)I*
g(I)
g(I*)
+ µS*
S
S*
h(S*)
h(S)
− (θ + µ)E −B(δ + µ)I* h(S)g(I)E*
h(S*)g(I*)E
+B(δ + µ)I*
+ (θ + µ)E −B(δ + µ)I* I
I*
−B(δ + µ)I*g(I*)
g(I)
E
E*
+B(δ + µ)I*
g(I*)
g(I)
I
I*
= µS*
(
1− S
S
− h(S*)
h(S)
+
S
S*
h(S*)
h(S)
)
+B(δ + µ)I*
(
2− h(S*)
h(S)
+
g(I)
g(I*)
− h(S)g(I)E*
h(S*)g(I*)E
− I
I*
− g(I*)
g(I)
E
E*
+
g(I*)
g(I)
I
I*
)
= µS*
(
1− S
S*
− h(S*)
h(S)
+
S
S*
h(S*)
h(S)
)
−B(δ + µ)I*
(
h(S*)
h(S)
+
h(S)g(I)E*
h(S*)g(I*)E
+
g(I*)E
g(I)E*
− 2
)
+B(δ + µ)I*
(
g(I)
g(I*)
− I
I*
+
I
I*
g(I*)
g(I)
)
= µS*
(
1− S
S*
)(
1− h(S*)
h(S)
)
−B(δ + µ)I*
(
h(S*)
h(S)
+
h(S)g(I)E*
h(S*)g(I*)E
+
g(I*)E
g(I)E*
− 3
)
+B(δ + µ)I*
(
g(I)
g(I*)
− I
I*
+
I
I*
g(I*)
g(I)
− 1
)
.
Now after rearrangement we obtain:
dV (S,E, I)
dt
= µS*
(
1− S
S*
)(
1− h(S*)
h(S)
)
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−B(δ + µ)I*
(
h(S*)
h(S)
+
h(S)g(I)E*
h(S*)g(I*)E
+
g(I*)E
g(I)E*
− 3
)
+B(δ + µ)I*
(
1− g(I*)
g(I)
)(
g(I)
g(I*)
− I
I*
)
.
Korobeinikov and Maini [12] explain that the concavity of the function g(I) ensures that dVdt ≤ 0, for all
S,E, I > a, where the equality holds only at the point Q*. Indeed, since the arithmetical mean is greater
than or equal to the geometrical mean (see also [12],
h(S*)
h(S)
+
h(S)g(I)E*
h(S*)g(I*)E
+
g(I*)E
g(I)E*
≥ 3, for all S,E, I > 0.
Furthermore, (
1− S
S*
)(
1− h(S*)
h(S)
)
≤ 0, for all S > 0,
since for a monotonically growing function h(S), h(S) ≥ h(S*) when S ≥ S* and h(S) ≤ h(S*) when
S ≤ S*. Also (
1− g(I*)
g(I)
)(
g(I)
g(I*)
− I
I*
)
if {
g(I)
g(I*) ≥ II* , for 0 < I ≤ I*,
g(I)
g(I*) ≤ II* , for I ≥ I*.
(3.53)
It is easy to see that this condition holds for all concave functions g(I) (see Figure 3.5). Since the
parameter a can be chosen sufficiently small, by the asymptotic stability theorem (see theorem 1.3.3), the
SEIR system (3.50) is globally asymptotically stable in R3+.
I*
I* I
g(I)
g
(
I*
)
Figure 3.5: A concave function g(I) as shown by Korobeinikov and Maini [12].
Proof of 2. To prove global stability of the infection-free equilibrium state Q0 = (1, 0) we consider, as in
[12], the Lyapunov test function:
U(S, I) = S − h(S0)
∫ S
a
dτ
h(τ)
+ E +BI,
where B = θ+µθ .
For system (3.50), the Lyapunov function satisfies
dU(S,E, I)
dt
=
(
1− h(S0)
h(S)
)
(µ− h(S)g(I)− µS) + (h(S)g(I)− (θµ)E) +B(θE − (δ + µ)I).
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Note that, for this SEIR system, B = θ+µθ :
dU(S,E, I)
dt
= µ− h(S)g(I)− µS − µh(S0)
h(S)
+ h(S0)g(I) + µS
h(S0)
h(S)
+ h(S)g(I)− (θ + µ)E + (θ + µ)E −B(δ + µ)I
= µ− µS − µh(S0)
h(S)
+ h(S0)g(I) + µS
h(S0)
h(S)
−B(δ + µ)I
= µ
(
1− h(S0)
h(S)
− S + Sh(S0)
h(S)
)
+ h(S0)g(I)−B(δ + µ)I,
which can be rearranged to give:
dU(S,E, I)
dt
= µ(1− S)
(
1− h(S0)
h(S)
)
+B(δ + µ)I
(
h(S0)
B(δ + µ)
g(I)
I
− 1
)
.
Using the same approach as in section 3.3 for the work in [12], we note that here
(1− S)
(
1− h(S0)
h(S)
)
≤ 0, for all S > 0,
and the conditions (3.17) and (3.19) ensure that g(I)I ≤ ∂g(0)∂I , for all I > 0. Hence, using R0, as defined in
(3.25), we have
h(S0)
B(δ + µ)
g(I)
I
≤ h(S0)
B(δ + µ)
∂g(0)
∂I
= R0.
Therefore, R0 ≤ 1 ensures that dVdt ≤ 0, for all S,E, I > a, and hence by the asymptotic stability theorem
(see theorem 1.3.3), the equilibrium state Q0 is globally asymptotically stable in this case. The theorem is
proven.
Chapter 4
Reaction and Diffusion Models
Throughout this section we will investigate reaction-diffusion systems. Following the work of Hsu [5], we
will consider the following reaction-diffusion system with Neumann boundary condition
∂u
∂t
= D∆u+ f(u) in Ω ⊆ Rn,
∂u
∂ν
= 0 in ∂Ω,
(4.1)
where u = u(x, t) ∈ Rn, D = diag(d1, . . . , dn), di > 0, i = 1, . . . , n, f : Rn+ → Rn is continuously
differentiable. We assume there exists a Lyapunov function V (u) for the corresponding ODE system
u′ = f(u). (4.2)
Thus we have that V (u) satisfies
V˙ (u) = graduV · f(u) ≤ 0 for all u ∈ Rn+. (4.3)
To study the global behaviour of system (4.1), Hsu [5] proves that the following functional is a Lyapunov
functional for the reaction-diffusion system (4.1).
W (t) =
∫
Ω
V (u(x, t))dx, (4.4)
for the proof, see [5].
We will use this result throughout this section to investigate the global behaviour of reaction-diffusion
systems.
4.0.3 A Diffusive Predator-Prey Model Given by Hsu [5]
The first reaction and diffusion system we will concentrate on is the following diffusive predator-prey system
investigated in [5]:
∂u
∂t
= d1∆u+ u(λ− αu− βv) in Ω,
∂v
∂t
= d2∆v + µv
(
1− v
u
)
in Ω,
∂u
∂ν
=
∂v
∂ν
= 0 in ∂Ω,
u(x, 0) = u0(x), v(x, 0) = v0(x) in Ω.
(4.5)
Here u(x, t) and v(x, t) respectively represent the species densities of the prey and predator and Ω ⊂ Rn is
a fixed bounded domain. Here we recall that ν is the outward unit normal vector on the smooth boundary
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∂Ω. Also note that the initial conditions u0(x) and v0(x) are continuous functions on Ω and the constants
di (i = 1, 2) are the diffusion coefficients corresponding to u and v respectively. All the parameters appear-
ing in (4.5) are assumed to be positive and we will use these assumptions for all of the reaction-diffusion
models we investigate.
We first calculate the equilibrium of the corresponding ODE system
du
dt
= u(λ− αu− βv) for t > 0,
dv
dt
= µv
(
1− v
u
)
for t > 0,
u(0) = u0 > 0, v(0) = v0 > 0.
(4.6)
Using (4.6) we can calculate the equilibrium as follows:
First we will consider dvdt = 0:
dv
dt
= µv*
(
1− v*
u*
)
= 0
⇒ 1− v*
u*
= 0
⇒ v* = u*.
Next we consider dudt = 0:
du
dt
= u*(λ− αu*− βv*) = 0.
Using v*=u* as calculated previously:
u*(λ− αu*− βu*) = 0
⇒ λ− (α+ β)u* = 0
⇒ u* = λ
α+ β
.
Thus we have the unique constant equilibrium (u*,v*) where u*=v*= λα+β .
Given the following Lyapunov function, constructed by Du and Hsu [4]:
V (u, v) =
∫ u
u*
ε− u*
ε2
dε+
β
µ
∫ v
v*
η − v*
η
dη, (4.7)
we can analyse the derivative V˙ (u, v) as follows.
Denote
f(u, v) = u(λ− αu− βv), g(u, v) = µv
(
1− v
u
)
. (4.8)
Using the formula, as stated by Hsu [5], we can calculate V˙ (u, v) as follows:
V˙ (u, v) =
∂V
∂u
f(u, v) +
∂V
∂v
g(u, v) (4.9)
=
u− u*
u2
[u(λ− αu− βv)] + β
µ
v − v*
v
[
µv
(
1− v
u
)]
=
u− u*
u
(λ− αu− βv) + β(v − v*)
(
1− v
u
)
.
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Note that, using the unique constant equilibrium point calculated previously, we have u*= λα+β ⇒ λ =
u*(α+ β), which can be substituted in to give:
V˙ (u, v) =
u− u*
u
(u*(α+ β)− αu− βv) + β v − v*
u
(u− v).
Using u*=v*, this can be rewritten as follows:
V˙ (u, v) =
u− u*
u
(αu*− αu) + u− v*
u
(βv*− βv) + β v − v*
u
(u− v)
= −α(u− u*)
2
u
+ β (v*− v)− β v*
u
(v*− v) + β (v − v*)− βv
(
v − v*
u
)
= −α(u− u*)
2
u
+ βv*
v − v*
u
− βvv − v*
u
= −α(u− u*)
2
u
− β (v − v*)
2
u
.
Thus we have
V˙ (u, v) = −α(u− u*)
2
u
− β (v − v*)
2
u
≤ 0. (4.10)
Consider now the potential Lyapunov functional for the reaction-diffusion system (4.6)
W (t) =
∫
Ω
V (u(x, t), v(x, t))dx,
we can calculate W ′(t) as follows:
W ′(t) =
∫
Ω
(Vuut + Vvvt) dx+
∫
Ω
V˙ dx
=
∫
Ω
(
u− u*
u2
d1∆u+
β
µ
v − v*
v
d2∆v
)
dx+
∫
Ω
V˙ (u, v)dx.
Using integration by parts, we have:
W ′(t) =
[∫
∂Ω
(
d1
u− u*
u2
∂u
∂ν
+
β
µ
d2
v − v*
v
∂v
∂ν
)
dx
−
∫
Ω
(
−d1
(
− 1
u2
+
2u*
u3
)
∇u · ∇u+ β
µ
d2
v*
v
∇v · ∇v
)
dx
]
+
∫
Ω
V˙ (u, v)dx
From the initial conditions ∂u∂ν =
∂v
∂ν = 0, given in system (4.5), ∇u · ∇u = |∇u|2 and ∇v · ∇v = |∇v|2, we
can eliminate the first integral and rearrange to obtain:
W ′(t) = −
∫
Ω
(
d1
2u*− u
u3
|∇u|2 + β
µ
d2
v*
v
|∇v|2
)
dx+
∫
Ω
V˙ (u, v)dx. (4.11)
If α > β then, from u*= λα+β , it can easily be seen that 2u*=
2λ
α+β >
2λ
2α =
λ
α . From the first equation in
(4.5), we have
∂u
∂t
≤ d1∆u+ u(λ− αu).
Let (u(x, t), v(x, t)) be a positive solution of system (4.5). Using a comparison argument we have 0 <
u(x, t) < U(x, t) for all t > 0 and x ∈ Ω, where U is the unique solution of
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
Ut = d1∆U + U(λ− αU) in Ω× (0,∞),
∂U
∂ν
= 0 on ∂Ω× (0,∞),
U(x, 0) = u0(x).
(4.12)
Thus from the comparison principle (see [19]), we can deduce that U(x, t)→ λα as t→∞ uniformly in x,
as also described by Du and Hsu [4]. Hence, from (4.10) and (4.25), we can easily see that W ′(t) < 0. We
can therefore conclude that when α > β, the constant equilibrium (u*, v*) attracts every positive solution
of system (4.5).
Next we will show how the restriction α > β can be relaxed by using the following Lyapunov function, as
given by Hsu [5]:
V *(u, v) =
∫ u
u*
ε2 − (u*)2
ε2
dε+ c
∫ v
v*
η − v*
η
dη, (4.13)
with c > 0 to be determined.
Using (4.8), we can now calculate V˙ *(u, v) as follows:
V˙ *(u, v) =
∂V *
∂u
f(u, v) +
∂V *
∂v
g(u, v) (4.14)
=
u2 − (u*)2
u2
[u(λ− αu− βv)] + cv − v*
v
[
µv
(
1− v
u
)]
=
u2 − (u*)2
u
(λ− αu− βv) + (v − v*)
(
1− v
u
)
=
1
u
[(
u2 − (u*)2) (λ− αu− βv) + cµ(v − v*)(u− v)] .
Note that, as calculated previously, we have the unique constant equilibrium point u*= λα+β ⇒ λ =
u*(α+ β):
V˙ *(u, v) =
1
u
[(u− u*)(u+ u*)(u*(α+ β)− αu− βv) + cµ(v − v*)(u− v)] .
Substituting in u*= v* and rearranging:
V˙ *(u, v) =
1
u
[−α(u− u*)2(u+ u*)− β(v − v*)(u− u*)(u+ u*) + cµu(v − v*)
−cµu*(v − v*) + cµv*(v − v*)− cµv(v − v*)]
=
1
u
[−α(u− u*)2(u+ u*)− β(v − v*)(u− u*)(u+ u*) + cµ(u+ u*)(v − v*)− cµ(v − v*)2]
=
1
u
[−α(u− u*)2(u+ u*) + [cµ− β(u+ u*)] (u− u*)(v − v*)− cµ(v − v*)2] .
Let ε = u− u* and η = v − v*, then we obtain:
V˙ *(u, v) =
1
u
[−α(u+ u*)ε2 + [cµ− β(u+ u*)] εη − cµη2] .
We can see that if
[cµ− β(u+ u*)]2 − 4α(u+ u*)cµ < 0, (4.15)
then we have
− α(u+ u*)ε2 + [cµ− β(u+ u*)] εη − cµη2 < 0 (4.16)
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unless ε = η = 0.
We can now show that the restriction α > β can be relaxed by choosing a c > 0 such that (4.16) holds.
Note that we can rewrite (4.16) as
(µc)2 − 2 (u+ u*) (β + 2α) (µc) + β2 (u+ u*)2 < 0. (4.17)
Here we can determine that (4.17) holds if and only if µc ∈ (c1, c2) where
c1 = c1(u) = (u+ u*)
(
β + 2α−
√
(β + 2α)2 − β2
)
,
c2 = c2(u) = (u+ u*)
(
β + 2α+
√
(β + 2α)2 − β2
)
.
To determine a more accurate c we will investigate to find when c1
(
λ
α
)
< c2(0) holds:
(
λ
α
+
λ
α+ β
)(
β + 2α−
√
(β + 2α)2 − β2
)
<
λ
α+ β
(
β + 2α+
√
(β + 2α)2 − β2
)
λ
α
(
β + 2α−
√
(β + 2α)2 − β2
)
<
2λ
α+ β
√
(β + 2α)2 − β2
(α+ β)
(
β + 2α−
√
(β + 2α)2 − β2
)
< 2α
√
(β + 2α)2 − β2
(α+ β)(β + 2α) < (3α+ β)
√
(β + 2α)2 − β2
(α+ β)2(β + 2α)2 < (3α+ β)2
[
(β + 2α)2 − β2]
(α+ β)2(β + 2α)2 < (3α+ β)2 [4α(α+ β)]
(α+ β)(β + 2α)2 < 4α(3α+ β)2.
This can be then expanded and rearranged to give:
32α3 + 16α2β − αβ2 − β3 > 0
32
(
α
β
)3
+ 16
(
α
β
)2
− α
β
− 1 > 0.
Let S = αβ , then we have:
h(S) = 32S3 + 16S2 − S − 1 > 0.
We can see that h(0) = h′(0) = −1, thus the cubic h(S) has a unique positive zero S0 and h(S) > 0 when
S > S0 (see also [4]). Since h
(
1
5
)
< 0 < h
(
1
4
)
, we can conclude that S0 ∈
(
1
5 ,
1
4
)
.
Now suppose that we have αβ > S0. We can see that c1
(
λ
α
)
< c2(0) holds and we can therefore choose an
ε > 0 small such that c1
(
λ
α + ε
)
< c2(0). Hence we can now choose a c > 0 such that
c1
(
λ
α
+ ε
)
< µc < c2(0).
Then we can see that
c1(u) ≤ c1
(
λ
α
+ ε
)
< µc < c2(0) ≤ c2(u), ∀u ∈
[
0,
λ
α
+ ε
]
.
Therefore, as also explained by Du and Hsu [4], for this choice of c, (4.17) holds for u ∈ [0, λα + ε]. We can
then see that
Z(u, v) := Vu*f + Vv*g ≤ 0, for all u ∈
[
0,
λ
α
+ ε
]
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where this equality holds if and only if (u, v) = (u*, v*).
Considering the potential Lyapunov functional
W*(t) =
∫
Ω
V *(u(x, t), v(x, t))dx
we can calculate the derivative as follows:
d
dt
W*(t) =
∫
Ω
(Vu*ut + Vv*vt) dx+
∫
Ω
Z(u, v)dx
=
∫
Ω
(
u2 − (u*)2
u2
d1∆u+ c
v − v*
v
d1∆v
)
dx+
∫
Ω
Z(u, v)dx.
Using integration by parts we obtain:
d
dt
W*(t) =
[∫
∂Ω
(
d1
u2 − (u*)2
u2
∂u
∂ν
+ cd2
v − v*
v
∂v
∂ν
)
dx
−
∫
Ω
(
d1
2(u*)2
u3
∇u · ∇u+ cd2 v*
v2
∇v · ∇v
)
dx
]
+
∫
Ω
Z(u, v)dx
= −
∫
Ω
(
d1
2(u*)2
u3
|∇u|2 + cd2 v*
v2
|∇v|2
)
dx+
∫
Ω
Z(u, v)dx.
As we know that u(x, t) < U(x, t)→ λα , shown previously, we can thus find T > 0 such that u(x, t) ≤ λα + ε
for t > T . Thus we have
d
dt
W*(t) ≤ 0 for t > T and equality holds if and only if (u, v) = (u*, v*).
We can therefore conclude that for αβ > S0, where S0 ∈ (15 , 14) is the unique positive zero of h(S) =
32S3 + 16S2 − S − 1, (u*, v*) attracts every positive solution of system (4.5).
4.0.4 A Diffusive Holling-Tanner Predator-Prey Model Given by Peng and Wang [18]
The next reaction-diffusion system we will concentrate on is the following diffusive predator-prey system
found in [18]: 
∂u
∂t
= d1∆u+ au− u2 − uv
m+ u
in Ω× (0,∞),
∂v
∂t
= d2∆v + bv − v
2
γu
in Ω× (0,∞),
∂u
∂ν
=
∂v
∂ν
= 0 on ∂Ω× (0,∞),
u(x, 0) = u0(x) > 0, v(x, 0) = v0(x) ≥ 0, 6≡ 0, on Ω¯.
(4.18)
Here we use the assumptions as defined in the example previously given by Hsu [5].
Firstly we will calculate the equilibrium of the corresponding ODE system as follows:
We will first consider dvdt = 0:
dv
dt
= bv*− (v*)
2
γu*
= 0
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⇒ v*
(
b− v*
γu
)
= 0
As we are interested in the positive equilibrium point, we have:
v* = bγu*. (4.19)
Now we will consider dudt = 0:
du
dt
= au*− (u*)2 − u*v*
m+ u*
= 0
⇒ u*
(
a− u*− v*
m+ u*
)
= 0.
As we are interested in the positive equilibrium point, we have:
a− u*− v*
m+ u*
= 0 (4.20)
⇒ u* (m+ u*) + v*− a (m+ u*) = 0.
Substituting in v*= bγu* as shown previously, we can rearrange to obtain:
(u*)2 + (m+ bγ − a)u*− am = 0
(4.21)
We can therefore solve to obtain the positive equilibrium point:
u* =
1
2
{
a−m− bγ +
√
(m+ bγ − a)2 + 4am
}
.
Thus we obtain the unique positive equilibrium point (u, v) = (u*, v*) where
u* =
1
2
{
a−m− bγ +
√
(m+ bγ − a)2 + 4am
}
and v* = bγu*.
Given the Lyapunov function, constructed by Peng and Wang [18]:
V (u, v) =
∫ u
u*
ε− u*
ε2
dε+ α
∫ v
v*
η − v*
η
dη, (4.22)
where α is a positive constant to be determined later.
Denote
f(u, v) = au− u2 − uv
m+ u
, g(u, v) = bv − v
2
γu
. (4.23)
Using the formula given previously in (4.9), we can calculate V˙ (u, v) as follows:
V˙ (u, v) =
∂V
∂u
f(u, v) +
∂V
∂v
g(u, v)
=
u− u*
u2
[
au− u2 − uv
m+ u
]
+
v − v*
v
[
bv − v
2
γu
]
.
Using equation (4.19), we can see that b = v*γu* and using equation (4.20), we can see that a = u*+
v*
m+u* .
Substituting and rearranging gives:
V˙ (u, v) =
u− u*
u
(
u* +
v*
m+ u*
− u− v
m+ u
)
+ α(v − v*)
(
v*
γu*
− v
γu
)
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= (u− u*)
(
u*− u
u
+
v*(m+ u)− v(m+ u*)
u(m+ u*)(m+ u)
)
+ α(v − v*)
(
v*
γu*
− v
γu
)
= (u− u*)
(
u*− u
u
+
m(v*− v) + uv*− u*v
u(m+ u*)(m+ u)
)
+ α(v − v*)
(
v*
γu*
− v
γu
)
= (u− u*)
(
u*− u
u
+
m(v*− v) + uv*− u*v + u*v*− u*v*
u(m+ u*)(m+ u)
)
+ α(v − v*)
(
v*
γu*
− v
γu
)
= (u− u*)
(
u*− u
u
+
v*(u− u*)− (m+ u*)(v − v*)
u(m+ u*)(m+ u)
)
+ α(v − v*)
(
v*
γu*
− v
γu
)
= (u− u*)2
(
−1
u
+
v*
u(m+ u)(m+ u*)
)
− (u− u*)(v − v*)
u(m+ u)
+ α(v − v*)
(
v*
γu*
− v
γu
+
v*
γu
− v*
γu
)
.
Using equation (4.19), we can see that b = v*γu* and using equation (4.20), we can see that
v*
m+u* = a− u*.
Substituting and rearranging gives:
V˙ (u, v) = (u− u*)2
(
−1
u
+
a− u*
u(m+ u)
)
− (u− u*)(v − v*)
u(m+ u)
+ α(v − v*)
(
b− bu*
u
− v − v*
γu
)
= (u− u*)2
(
−1
u
+
a− u*
u(m+ u)
)
− (u− u*)(v − v*)
u(m+ u)
+ α(v − v*)
(
b(u− u*)
u
− v − v*
γu
)
= (u− u*)2
(
−1
u
+
a− u*
u(m+ u)
)
+ (u− u*)(v − v*)
(
bα
u
− 1
u(m+ u)
)
− (v − v*)2 α
γu
Since m > bγ, as stated by Peng and Wang [18], we note that 2u*−u > 0 for x ∈ Ω¯ and t  1. We will
also suppose that there exists positive constants α and t0 such that for all x ∈ Ω¯ and t ≥ t0; the solution
(u(x, t), v(x, t)) of system (4.18) therefore satisfies:
V˙ (u, v) = (u− u*)2
(
−1
u
+
a− u*
u(m+ u)
)
+ (u− u*)(v − v*)
(
bα
u
− 1
u(m+ u)
)
− (v − v*)2 α
γu
≤ 0. (4.24)
Considering the potential Lyapunov functional for (4.18)
W (t) =
∫
Ω
V (u(x, t), v(x, t))dx,
we can calculate W ′(t) as follows:
W ′(t) =
∫
Ω
(Vuut + Vvvt) dx+
∫
Ω
V˙ (u, v)dx
=
∫
Ω
(
u− u*
u2
d1∆u+ α
v − v*
v
d2∆v
)
dx+
∫
Ω
V˙ (u, v)dx
=
[∫
∂Ω
(
d1
u− u*
u2
∂u
∂η
+ αd2
v − v*
v
∂v
∂η
)
dx
−
∫
Ω
(
−d1
(
− 1
u2
+
2u*
u3
)
∇u · ∇u+ αd2 v*
v
∇v · ∇v
)
dx
]
+
∫
Ω
V˙ (u, v)dx.
From the initial conditions ∂u∂ν =
∂v
∂ν = 0, given in system (4.18), ∇u · ∇u = |∇u|2 and ∇v · ∇v = |∇v|2, we
can eliminate the first integral and rearrange to obtain:
W ′(t) = −
∫
Ω
(
d1
2u*− u
u3
|∇u|2 + αd2 v*
v
|∇v|2
)
dx+
∫
Ω
V˙ (u, v)dx ≤ 0 (4.25)
Therefore we can see that (u(x, t), v(x, t))→ (u*, v*) in [L∞ (Ω)]2. Thus this shows that (u*, v*) attracts
all solutions of the system (4.18) and (u*, v*) is globally asymptotically stable.
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4.0.5 A New Diffusive SIRS System
The final reaction-diffusion system we will investigatee is associated with the SIRS system considered in
[13]. This system has been edited throughout the analysis of this system to use variables P and I which
can be seen in system (3.2). In particular we consider the following reaction-diffusion system:
∂P
∂t
= d1∆P + γˆN − βPI
N
− σˆP in Ω,
∂I
∂t
= d2∆I + β
PI
N
− δˆI in Ω,
∂u
∂ν
=
∂v
∂ν
= 0 in ∂Ω,
P (x, 0) = P0(x), I(x, 0) = I0(x) in Ω,
(4.26)
where we use the assumptions as defined in the example previous given by Hsu [5].
Note that we have calculated the endemic equilibrium point in (3.3) which can therefore be used in this
analysis. We recall that the following is a Lyapunov functional for the corresponding ODE system
V (P, I) = P*
(
P
P*
− ln P
P*
)
+ I*
(
I
I*
− ln I
I*
)
, (4.27)
since we have already proved V˙ ≤ 0 in (3.8). Now we consider the potential Lyapunov functional for the
reaction-diffusion system (4.26)
W (t) =
∫
Ω
V (u(x, t), v(x, t))dx,
and continue to calculate W ′(t) as follows:
W ′(t) =
∫
Ω
(VPPt + VIIt) dx+
∫
Ω
V˙ (u, v)dx
=
∫
Ω
((
1− P*
P
)
d1∆P +
(
1− I*
I
)
d2∆I
)
dx+
∫
Ω
V˙ (u, v)dx.
Using integration by parts, we have:
W ′(t) =
[∫
∂Ω
(
d1
(
1− P*
P
)
∂P
∂ν
+ d2
(
1− I*
I
)
∂I
∂ν
)
dx
−
∫
Ω
(
d1
P*
P 2
∇P · ∇P + d2 I*
I2
∇I · ∇I
)
dx
]
+
∫
Ω
V˙ (u, v)dx.
From the initial conditions ∂u∂ν =
∂v
∂ν = 0, given in system (4.26), ∇u · ∇u = |∇u|2 and ∇v · ∇v = |∇v|2,
we can eliminate the first integral and rearrange to obtain:
W ′(t) = −
∫
Ω
(
d1
P*
P 2
|∇P |2 + d2 I*
I2
|∇I|2
)
dx+
∫
Ω
V˙ (u, v)dx.
Therefore, using V˙ ≤ 0 as previously stated, it can easily be seen that
W ′(t) = −
∫
Ω
(
d1
P*
P 2
|∇P |2 + d2 I*
I2
|∇I|2
)
dx+
∫
Ω
V˙ (u, v)dx ≤ 0. (4.28)
Thus we can conclude that the reaction and diffusion system (4.26) has a globally asymptotically stable
endemic equilibrium point E* defined in (3.3).
As far as we aware the above result is the first stability result in the literature associated to system (4.26).
Chapter 5
Conclusion and Further Work
Throughout this thesis we have investigated the use of Lyapunov functions to determine global behaviour
of ODE and PDE systems for a variety of models. The models we have concentrated on in this work are
ODE systems for population models, specifically predator-prey models; ODE systems for epidemiological
models, in particular we have investigated SIRS, SIR, SIS and SEIR models; and PDE systems for
reaction-diffusion models, for predator-prey models and an SIR model. We will further evaluate each of
these different models individually and the future work we can achieve through more detailed investigation.
Predator-Prey Models
We have analysed the global behaviour of population dynamics through examples of ODE systems of
predator-prey models including a competing predator-prey model. We have been able to determine that
each of these models have globally asymptotically stable equilibrium points by using Lyapunov functions
previously constructed. Further investigation of this work would include the analysis of alternative inter-
actions. As explained by Murray [15], there are a further two main types of interactions we could explore.
The first type of interaction is competition, where the growth rate of each population is decreased and the
second type is mutualism for which each population’s growth rate is enhanced. Both scenarios would create
a greatly differing models for which Lyapunov functions can be created to analyse their global behaviour.
Epidemiological Models
This thesis has used Lyapunov functions to investigate the global behaviour of numerous epidemiological
models through examples of ODE systems of SIR, SIRS, SIS and SEIR models. Lyapunov functions have
been used to prove each of the examples used have a globally asymptotically stable endemic equilibrium
points. Further analysis of this work would include investigating different models with convex functions as
opposed to concave. Anther aspect of further investigation would include decreasing assumptions to create
a better representation of the real world situation. An example of this would be to remove the assumption
that birth rates are equal to death rates. An additional possibility of further research would include using
data provided on past epidemics to analyse the suitability of different epidemiological models to determine
whether the data either follows or contradicts our results of their global behaviour.
Reaction-Diffusion Models
We have used PDE systems of different types of reaction-diffusion models and applied our work on Lyapunov
functionals to determine their global behaviour. We have studied diffusive predator-prey models given
and determined they have globally asymptotically stable equilibrium points. We have then continued to
create our own reaction-diffusion model by expanding on an SIRS model and the corresponding Lyapunov
function given. To our knowledge this is the first time this work has been done for this model and we have
been able to conclude that this also has a globally asymptotically stable equilibrium point. Further analysis
on reaction-diffusion models would include investigating the dynamics of an ODE system in comparison
to the dynamics of the corresponding reaction-diffusion system when diffusion is added and determining if
diffusion changes the systems global behaviour.
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